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Abstract 
CD4
+
 T cells play a central role in controlling the adaptive immune response by secreting 
cytokines to control the responses of different lymphocytes. Naïve CD4
+
 T cells differentiate into 
at least four subsets, Th1, Th2, Th17, and inducible regulatory T cells under antigen and 
corresponding cytokine microenvironment during an immune response. Therefore, each subset 
has unique functions for pathogen elimination. The differentiation of these subsets is induced in 
response to conditioned cytokine stimulation, which induces specific master regulator 
transcription factors. Multiple other transcription factors, both subset specific and shared, are 
also involved in promoting subset differentiation. Previously, our group has discovered that early 
growth response gene-2 (Egr-2) is important for the maintenance of T cell homeostasis and 
controls the development of autoimmune disease. However, the underlying mechanisms are 
unknown. In this study, using Egr-2 conditional knockout mice, a novel mechanism of Egr-2 in 
the control of Th17 differentiation has been discovered. Egr-2 is induced by TGFβ and IL-6 in 
naïve CD4
+
 T cells. The induced Egr-2 negatively regulates the expression of IL-17, the 
signature cytokine for Th17. In contrast, Egr-2 has less effect on the expression of IL-2 or IFN-γ 
in effector T cells. In the absence of Egr-2, CD4
+
 T cells produce high levels of Th17 cytokines. 
Deletion of Egr-2 in T cells renders mice susceptible to EAE induction; a model for Th17 
mediated autoimmune diseases. T cells lacking Egr-2 show increased propensity for Th17, but 
not Th1 or Th2, differentiation in vitro. The key mechanism of Egr-2 in regulation of Th17 
differentiation is to inhibit the function of Batf for transactivation of IL-17 expression and 
promotion of Th17 differentiation. Egr-2 interacts with Batf in CD4
+
 T cells and suppresses its 
interaction with DNA sequences derived from the IL-17 promoter, while the activation of 
STAT3 and expression of RORγt is unchanged in Th17 cells in the absence of Egr-2. Thus, Egr-
14 
2 plays an important role to intrinsically control Th17 differentiation. We also found that CD4
+
 T 
cells from multiple sclerosis (MS) patients have reduced expression of Egr-2 and increased 
expression of IL-17 following stimulation with anti-CD3 in vitro. Collectively, our results 
demonstrate that Egr-2 is an intrinsic regulator that controls Th17 differentiation by inhibiting 
Batf activation which may be important for the control of inflammatory autoimmune diseases. 
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1 INTRODUCTION 
1.0 CD4+ T cells 
The immune system consists of a sophisticated array of cells that have developed to recognize 
and eradicate a wide variety of microorganisms. It has been well established that to evade and 
overcome the innate immune response leads to the activation of adaptive immunity where the 
response is shaped depending on the pathogen eliciting the reaction (Janeway 1989). In adaptive 
immunity CD4
+
 T cells (a major subset of T lymphocytes) play a central role in immune 
protection. T cells originate in the bone marrow, and go to the thymus where they mature and 
develop. They then exit to the peripheral immune system, and can be stimulated by antigen-
presenting cells (APCs) that carry the major histocompatibility complex (MHC) presented with a 
peptide antigen. This is the stage that T cells will produce the cytokine IL-2 and express IL-2 
receptors on the surface. Binding of IL-2 to its receptors, through the autocrine mechanism, 
induces clonal expansion of T lymphocytes. The activated T lymphocytes are subsequently 
differentiated to the effector cells for generating immune functions (see Fig 1-1, A-C).  
In contrast to the MHC class I restricted CD8
+
 T cells, CD4
+
 T cells recognize antigen in context 
with MHC class II molecules (Janeway 1989). Importantly, CD4
+
 T cells do not directly react on 
antigen-bearing target cells, but produce cytokines that regulate the function of different 
lymphocytes during immune responses (Tseng and Dustin 2002); so CD4
+
 T cells are known as 
helper T cells (Th cells). CD4
+
T cells are critical for host defense, but if they lose tolerance to 
self-antigens, they can also derive autoimmune diseases, asthma, and allergies (Stefanova, 
Dorfman et al. 2002). Based on the antigen and cytokine environment, CD4
+
 T cells  
17 
differentiate into different subsets of T helper cells. The different Th subsets are defined by the 
signature cytokines produced in response to antigen stimulation (Jiang and Dong 2013). Th1 and 
Th2 cells are the classical Th subsets (Mosmann, Cherwinski et al. 2005). The mechanisms for 
Th1 and Th2 differentiation, the cytokines produced by Th1 and Th2 cells and the key 
transcription factors regulating the plasticity of these Th cells are well documented. See Fig 1.2 
(O'Garra and Arai 2000). Further investigations in recent years demonstrate that the 
opportunities for helper diversity are far greater than just these two outcomes. The new diversity 
includes Th17, Th9, and Th22 cells; follicular helper T (TFH) cells; and different types of 
regulatory T (Treg) cells. Figure 1-3 (Hirahara, Poholek et al. 2013). In addition, the emerging 
data point to the increased flexibility of these subsets. Understanding the molecular basis of this 
complexity is now a major focus in immunology, and the new insights will provide a better 
understanding of immune-mediated disease and new opportunities for therapy. 
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Figure 1-1. Schematic overview of naive T cells upon activation. 
(A) Cell surface receptors expressed on naive CD4+ T cells. (B) Flow chart showing upon encounter to 
antigen, CD4
+
 T cells will clonally expand to T helper cells and differentiate to specific subsets of T 
helper cells. These effector CD4
+ 
T cells go on to eliminate foreign antigens by secreting cytokines 
and then stay as memory T cells already having previous exposure to the antigen. (C) Diagram 
showing APC carrying the MHC class II molecule presenting the antigen, binding to naive T cells 
along with the co stimulatory molecules activates the CD4
+ 
T cell to produce IL-2 and have Il-2 
receptors on its surface which leads to clonal expansion of T helper cells. 
19 
 
 
Figure 1-2. Differentiation and function of Th1 and Th2 cells. Adapted from (O'Garra and Arai 
2000). 
 
APCs, partly due to the cytokines that they produce, can induce the development of Th1 or Th2 cells. 
Naive CD4
+
 T cells can develop into Th1 cells responsible for cell-mediated immunity in response to IL-
12. Th1 development is dependent on IFN-γ, and maintenance of phenotype depends on stimulation in the 
presence of IL-12 and IL-18. Development of Th1 responses can be antagonized directly by IL-4 and 
indirectly by IL-10. Th2 cells, dependent on IL-4 to differentiate, and IL-1a for maintenance. Regulatory 
T cells have a suppressive function and this is part due to the action of transforming growth factor beta 
(TGF- β) and the ability to inhibit both Th1 and Th2 development.  
20 
 
Figure 1-3. T helper subsets: What we knew before and what we know now. Taken from (Hirahara, 
Poholek et al. 2013). More than two decades ago, helper T cells were viewed as having two major fates, 
Th1 and Th2 cells. We now recognize the new diversity of helper T cells including Th17, Th9, Th22, Tfh 
and different types of regulatory T cells. 
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1.1 Regulation of Th1 and Th2 cell differentiation 
1.1.1 Cytokine induced development of Th1 and Th2 subsets 
Early events in an immune response stimulate the production of cytokines, antigen-presenting 
cells (APCs) or a specific APC subset (e.g. distinct dendritic cell subsets), depending on 
cytokines that they produce, they can induce the development of Th1 or Th2 cells with discreet 
patterns of cytokine production.  
Naive CD4
+
 T cells can develop into Th1 cells by production of their hallmark pro-inflammatory 
cytokines interferon-γ (IFN-γ) as well as lymphotoxin, IL-2 and IL-10. They are responsible for 
directing cell-mediated immune responses, which leads to eradication of intracellular pathogens 
(Mosmann and Coffman 1989; Sher and Coffman 1992) including bacteria, viruses, parasites and 
yeasts. Maintaining the phenotype depends on stimulation in the presence of IL-12 and IL-18 
(See figure 1-2). IL-12 is the dominant factor in directing the development of Th1 cells 
producing high levels of IFN-γ (Hsieh, Macatonia et al. 1993; Trinchieri and Scott 1995). IL-12 
is a 75kDa heterodimer, produced by macrophages upon encounter with many microbial 
products. APCs are specialized in antigen capture, migration to secondary lymphoid organs, T 
cell priming (Steinman 1991) and can also produce IL-12 (Scheicher, Mehlig et al. 1995). A Th1 
response is often accompanied by the production of complement-fixing antibodies of the IgG2a 
isotype, as well as the activation of natural killer (NK) cells and cytotoxic CD8
+ 
T cells 
expressing IFN-γ and perforin (Mosmann, Cherwinski et al. 1986; Sher and Coffman 1992; 
22 
Abbas, Murphy et al. 1996; Mosmann and Sad 1996). If uncontrolled, aberrant Th1 response can 
cause tissue damage or contribute to several inflammatory and autoimmune diseases such as 
multiple sclerosis (MS), type 1 diabetes and inflammatory bowel disease (Powrie and Coffman 
1993; Liblau, Singer et al. 1995). 
Human asthma, as well as animal models of allergic airway inflammation, revealed the 
importance of cytokines produced by Th2 cells, namely IL-4, IL-5, and IL-13 (Umetsu and 
DeKruyff 2006). Th2 cells activate mast cells and eosinophils and in addition can result in 
elevated levels of IgE and so have been implicated in atopy and allergic inflammation 
(Romagnani 1994). Th2 cells are dependent upon naïve CD4
+
T cells exposure to IL-4 for 
differentiation at the initiation of an immune response (Swain, Weinberg et al. 1990). The effects 
of IL-4 in inducing Th2 development are dominant over Th1 polarizing cytokines (Hsieh, 
Heimberger et al. 1992; Seder and Paul 1994). So when IL-4 levels reach a certain threshold at 
the beginning of an immune response Th2 cells will differentiate, leading to increased levels of 
IL-4 progressively. This could explain why during an innate immune response where chronic 
stimulation takes place in the absence of inflammatory signals as well as the  magnitude of an 
immune response could possibly drive Th2 responses (Abbas, Murphy et al. 1996). It was 
originally thought that IL-4 was only produced by differentiated T helper cells early in an 
immune response. There are now several candidates for IL-4 production occurring  early in an 
immune response which could be possible for Th2 differentiation; these include MHC class II 
restricted CD4
+
T cells (memory and naïve) (Hosken, Shibuya et al. 1995), the natural killer 1 
(NK1
+
) of CD4
+ 
and double negative (DN) T cells (reviewed in (Bendelac, Rivera et al. 1997), 
and non-T cell sources, such as mast cells, basophils and eosinophils (Paul, Seder et al. 1993). 
The production of B cell growth and differentiation factors by Th2 cells may explain why certain 
23 
immune responses are predominantly humoral, whereas delayed-type hypersensitivity is 
attributed to Th1 cells.  
1.1.2 Th1 and Th2 paradigm 
Cytokines from Th1 and Th2  can cross-regulate each other‘s function as well as development. 
The development of Th1 responses can be antagonized directly by IL-4 and indirectly by IL-10, 
which inhibits the production of inflammatory mediators such as IL-12 and IL-18 from 
macrophages and/or dendritic cells stimulated by the innate immune response (Moore, O'Garra et 
al. 1993). IFN-γ produced by Th1 cells inhibits the development of Th2 cells (Fitch, McKisic et 
al. 1993) as well as humoral responses. 
Helper T cells and clones that produce both Th1 and Th2 type cytokines (termed Th0) have been 
described in human and mouse systems (Sher and Coffman 1992; Kelso 1995; Abbas, Murphy et 
al. 1996). Whether they are precursors for Th1 and Th2 subsets is still not clear; it is possible 
they are involved in eliminating many pathogens, where a balance of both regulated and an 
appropriate humoral response will eradicate the invading pathogen with little immunopathology. 
However in a chronic setting it could be pathogenic as the polarized Th1 and Th2 responses 
could have counter regulatory effects of cytokines from each subset.  
In the past year, it has become clear that distinct subsets of regulatory T cells are responsible for 
regulating both Th1 and Th2 responses and preventing the development of immune pathologies. 
A common feature of many of these regulatory T cells is that their function is related to the 
action of transforming growth factor beta (TGF-β); this would be in keeping with the ability of 
TGF-β to inhibit both Th1 and Th2 development. 
24 
The attempt to link common autoimmune diseases with a simple Th1/Th2 paradigm has been 
problematic (Gor, Rose et al. 2003) even though there is evidence that excessive activation of 
Th1 cells contributes to organ-specific autoimmune diseases (Szabo, Sullivan et al. 2003). 
However, a number of lines of evidence suggest that autoimmune mechanisms cannot be reduced 
to the action of Th1 cells alone. In particular, the discovery of a new cytokine, IL-23, led to the 
recognition of a new subset of helper T cells and their importance in autoimmunity (Cua, 
Sherlock et al. 2003). 
1.1.3 Costimulatory molecules and the control of Th1 and Th2 differentiation 
The differentiation pathway for Th1 and Th2 cell development can be influenced by a number of 
factors, including the dose and form of antigen, the affinity of the peptide antigen T cell receptor 
(TCR) interaction (Constant and Bottomly 1997) and costimulatory interactions between cell-
surface molecules. Appropriate Th lymphocyte stimulation requires two signals. The first 
response is by interaction of the T cell receptor (TCR) on the Th cell and the peptide-MHC 
complex on the APC. This signal is not sufficient to activate T cells due to the absence of a 
second signal from costimulatory molecules; TCR binding may result in anergy or cell death 
(Schwartz 1990). Adhesion and costimulatory molecules, which deliver the second signal to T 
cells, stabilize intercellular binding and  influence Th1 and Th2 differentiation. The most 
important costimulatory molecule is CD28, which interacts with members of the B7 family. 
Other costimulatory interactions include ICAM-1 and LFA-1; CD40 and CD40L participate in 
the cross-talk between Th cells and APCs, they also influence the outcome of the response. 
These molecules modulate the duration and strength of Th cell activation and, similarly to that 
recognized for the antigen dose.  Also the affinity of the peptide MHC complex to the TCR, have 
an effect on Th1 and Th2 cell differentiation (Gause et al. 1997;Ruedl et al. 2000). It has been 
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seen that ICAM-1 and LFA-1 interactions inhibit the expression of Th2 cytokines (Luksch, 
Winqvist et al. 1999). Although these factors might offer some explanation to the development 
of distinct Th cell subsets, cytokines are major inducers of Th cell differentiation (Paul and Seder 
1994). In addition to the expression of distinct cytokine genes, the molecular basis for 
commitment to a Th1 or Th2 phenotype can probably be explained by multiple mechanisms, 
including exclusive cytokine receptor expression, differential cytokine signalling, differential 
expression of transcription factors and differential chromatin remodelling of Th1 and Th2 
specific genes (Rincon and Flavell 1997; Agarwal and Rao 1998). 
 There are two main systems used for studying the factors driving Th1 and Th2 development. 
These are the polyclonal stimulation of T cells, triggering the TCR with antibody against CD3 
together with the costimulator anti-CD28, and the stimulation of T cells derived from TCR-
transgenic mice with specific antigen and APC. Using these systems, researchers have shown 
that cytokines such as IL-12 and IL-4 play a dominant role in inducing the differentiation of Th1 
and Th2 cells, respectively (O'Garra, Steinman et al. 1997; Murphy, Ouyang et al. 2000). Naive 
T cells differentiate into homogeneous populations of committed Th1 or Th2 cells displaying an 
exclusive cytokine pattern. This is achieved mostly after repeated antigenic stimulation under the 
appropriate conditions. Th1 and Th2 populations are heterogeneous at an early stage in 
development, contain low frequencies of cytokine-producing cells and are reversible, suggesting 
that a number of molecular changes must occur in order to establish a committed profile of 
cytokine gene expression. 
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1.1.4 Signaling pathways for Th1 differentiation and commitment 
The activation of the transcription factor STAT4 by IL-12 and through the IL-12 receptor (IL-
12R) is crucial for Th1 responses. (Figure1-4, adapted from O‘Garra and Arai 2000). The IL-12 
receptor consists of two chains, IL-12Rb1 and IL-12Rb2, and mice deficient in IL-12 and 
STAT4 have markedly reduced, but not absent, Th1 responses (Magram, Connaughton et al. 
1996; Thierfelder, van Deursen et al. 1996). It has been shown that STAT4 can bind to DNA-
binding sites within the gene encoding IFN-γ, but differentiated T cells can produce IFN-γ in the 
absence of STAT4 (Ouyang, Jacobson et al. 1999). Also IFN-γ can activate STAT4 in human T 
cells but not in mice (Rogge, D'Ambrosio et al. 1998). 
The receptor IL-12Rb2 is expressed in Th1 cells and is upregulated by IFN-γ, whereas Th2 cells 
lose the expression of this chain of the IL-12R by downregulation with IL-4,  researchers have 
hypothesized this as a basis for Th1 commitment (Szabo, Dighe et al. 1997). Work by 
Nishikomori and his group and also Heath and his group have shown; ectopic expression of IL-
12Rb2 in developing Th2 cells results in activation of STAT4 by IL-12 and to proliferate it does 
not lead to significant production of IFN-γ, suggesting that IL-12 driven STAT4 activation is not 
sufficient to maintain IFN-γ production by Th cells (Heath, Showe et al. 2000; Nishikomori, 
Ehrhardt et al. 2000). 
IL-18 has recently been shown to synergize with IL-12 to stimulate the production of IFN-γ by 
Th1 cells and both chains of the IL-18 receptor are downregulated on Th2 cells but maintained 
on Th1 cells (Xu, Chan et al. 1998). IL-18 signals autophosphorylation of IRAK and activation 
of NF-kB52. Further, more mouse studies by Magram and Takeda have shown that IL-18 as well 
as IL-12-deficient mice show a defect in Th1 responses (Magram, Connaughton et al. 1996; 
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Takeda, Tsutsui et al. 1998). Mice deficient in IRF-1 have also shown a defect in development of 
Th1 cells and IFN-γ production, both at the level of IL-12 production by the APC and at the 
responsiveness of the Th1 cells to IL-12. This could be explained by studies showing that IRF-1 
(Interferon regulatory factor 1) is a target gene of IL-12 (Coccia, Passini et al. 1999). 
Exposure of cells to cytokines and environmental stresses activates the MAP (Mitogen activated 
protein) kinases c-Jun N-terminal kinase (JNK) and p38 pathways. Targets of these pathways 
include transcription factors such as c-Jun and ATF2 (Activating Transcription Factor 2). 
Activation of c-Jun and ATF2 plays an important role in activating cytokine genes in the innate 
and adaptive immune response. 
In Jnk2
–/–
 T cells, a large reduction in IFN-γ production was seen, which in part could be 
explained by a decreased expression of IL-12Rb2 and reduced STAT4 activation required for 
IFN-γ production (Yang, Conze et al. 1998). In another study, a dominant-negative inhibitory 
mutant of p38 selectively impaired Th1 responses and activation of the IFN-γ promoter (Rincon, 
Enslen et al. 1998). 
Both the proximal and distal elements in transgenic reporter mice direct reporter expression in 
memory CD4
+ 
effector T cells. The consensus GATA motif is contained in the distal sites, also a 
potential regulatory motif found in the promoter regions of other cytokine genes, and factors 
binding to this site included GATA-3. GATA-3 is of interest as expression has since been shown 
to be Th2 specific and crucial for differentiation of Th2 cells (Lee, Takemoto et al. 2000). 
NFAT and NF-kB have also been shown to bind to similar regions in the first intron of the IFN-γ 
gene (Sica, Dorman et al. 1997). A ubiquitous nuclear factor, Yin-Yang 1 (YY1), has been 
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shown to bind to two regions of the IFN-γ promoter and is proposed to act as a repressor of basal 
IFN-γ transcription (Ye, Cippitelli et al. 1996). Although these transcription factors have been 
proposed to regulate IFN-γ expression, future detailed functional analysis is needed to define 
their specific roles. 
 
Figure 1-4. Regulation of Th1 and Th2 differentiation 
Adapted from (O'Garra and Arai 2000) IL-12 and IL-4 direct the development of Th1 and Th2 
subsets respectively, producing IFN-γ through STAT4 in Th1 cells or IL-4 through STAT6 
dependent pathway in Th2 cells. 
1.1.5 Transcription factors in Th1 development and commitment 
Studies by Szabo, Glimcher and colleagues have found a cDNA encoding a protein they term T-
bet (T-box gene expressed in T cells, since it is selectively expressed in thymocytes and Th1 
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cells) (Szabo, Kim et al. 2000). T-bet belongs to the T box family of transcription factors and 
play important roles in diverse developmental processes. T-bet was rapidly and selectively 
induced in Th1 but not Th2 cells. Co-transfection of the mouse thymoma (EL4) with a T-bet 
expression plasmid and an IFN-γ-luciferase reporter construct (containing the entire IFN-γ gene 
locus) results in significant T-bet-specific transactivation of the IFN-γ gene in both stimulated 
and unstimulated cells. Contrastingly, the activity of the IL-2 promoter is repressed by T-bet 
expression. This could explain previous observations that, although Th1 cells express IL-2, they 
downregulate its expression as they differentiate. Interestingly, T-bet neither inhibited nor 
enhanced IL-4 promoter transactivation. 
After a week of culture the reversibility of Th1 and Th2 populations is mostly abrogated; 
however, stable commitment to a Th phenotype occurs only after repeated stimulation under 
polarizing conditions (Murphy, Shibuya et al. 1996). Interestingly, the introduction of T-bet into 
stably committed Th2 populations also dramatically increased the numbers of IFN-γ-producing 
cells and reduced the number of IL-4 and IL-5 producing cells, showing T-bet can convert Th2 
into Th1 cells. However, ectopic expression of T-bet in a homogeneous Th2 clone only increased 
minimally the number of IFN-γ-producing cells. This might be because the chromatin 
configuration at the relevant loci is no longer accessible or because of the other factors necessary 
for inducing IFN-g gene expression is no longer present. However, T-bet expression in the Th2 
clone still resulted in a significant reduction of IL-4 and IL-5-producing cells, showing that the 
ability of T-bet to suppress Th2 development extends even to long-term clones. So T-bet both 
initiates Th1 genetic programmes and represses the opposing Th2 programmes. 
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1.1.6 Signaling pathways for Th2 differentiation and commitment 
Production of IL-4 early in an immune response directs the development of a Th2 response. 
Ligation of IL-4 with its receptor (IL-4R) activates at least two signaling pathways JAK–STAT 
and IRS2 (Insulin receptor substrate 2) pathways. Studies have showed that STAT6-deficient 
mice had defects in Th2 responses (Takeda, Tanaka et al. 1996), similar to the phenotype of IL-
4-deficient mice, showing a crucial role of STAT6 in inducing Th2 differentiation. The STAT6-
mediated signalling cascade was further studied by using a conditionally active form of STAT6 
(STAT6:ER) which mimics IL-4-mediated signalling without ligation of the IL-4 receptor 
(Kurata, Lee et al. 1999). STAT6:ER, a fusion protein of STAT6 and the hormone-binding 
domain of the oestrogen receptor, is activated independently of IL-4 by an oestrogen analogue, 
4-hydroxytamoxifen (4-HT). Work from Kurata and his group has shown that when STAT6:ER 
was transduced retro virally into naive T cells from mice with a transgenic T-cell receptor  and 
driven under Th1 conditions. Activation of STAT6:ER induced the production of IL-4, IL-5 and 
IL-10 and repressed Th1 development and production of IFNγ although there was inhibition of 
the IL-12Rb2 receptor. Also a change in cytokine profile and the induction of mRNA for the 
Th2-specific transcription factors GATA-3 and c-maf was also observed upon the activation of 
STAT6:ER, suggesting that GATA-3 and c-Maf are downstream from STAT6 in the IL-4R 
mediated signalling cascade in Th2 development (Kurata, Lee et al. 1999). Studies by Ouyang et 
al, demonstrated that STAT6-independent GATA-3 autoactivation can direct IL-4-independent 
Th2 development and commitment (Ouyang, Lohning et al. 2000). In addition to these dominant 
pathways for Th2 cell differentiation, there might be crosstalk with other signaling pathways and 
so a requirement for other signaling molecules, such as the Tec (T cell-associated kinases) family 
kinase, which is required for the development of Th2 cells (Fowell, Shinkai et al. 1999). 
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1.1.7 Transcription factors for Th2 development and commitment 
A number of transcription factors have  shown to be implicated in Th2 cell differentiation. These 
include STAT6, NFATc/2, NF-IL-6, AP-1/Jun-β, c-Maf and GATA-3. Although AP-1 and 
NFAT proteins are important for inducing IL-4 and IL-5 transcription, they are present in both 
Th1 and Th2 subsets and so do not account for the Th2-restricted expression of IL-4. However, 
mice bearing targeted disruptions of NFATp have increased Th2 cytokines in the late phase of 
the immune response (Kiani, Viola et al. 1997). In addition, mice lacking both NFAT4/x and 
NFATp have extremely high levels of IL-4 and IgE (Ranger, Oukka et al. 1998), Showing that 
NFATp and NFAT4/x can exert a negative regulatory role on IL-4 expression in vivo, whereas 
NFATc positively transactivates the IL-4 promoter (Szabo, Glimcher et al. 1997).  
GATA-3 and c-Maf are two Th2-specific transcription factors, c-Maf, an oncoprotein, is reported 
to activate the IL-4 promoter. c-Maf-deficient mice have been shown to be defective in IL-4 
production but, interestingly other Th2-specific cytokines were unaffected (Kim, Ho et al. 1999). 
Ectopic expression of c-Maf did not induce the expression of IL-4 in developing Th1 cells.  
Several investigators have demonstrated the importance of GATA-3 in Th2 cytokine gene 
expression and Th2 differentiation. Th1 cells from transgenic mice expressing GATA-3 have 
shown an increase in IL-4, IL-10 and IL-6 mRNA expression, although an effect on IFN-γ was 
not observed. Furthermore, expression of antisense GATA-3 in a Th2 clone significantly 
inhibited the expression of Th2 cytokines upon activation (Zheng and Flavell 1997)
.  
Retroviral 
infection of naive T cells with GATA-3 when cultured under Th1 conditions induced the 
production of Th2-cytokines and downregulated IFN-γ production through repression of IL-12 
signaling (Ouyang, Ranganath et al. 1998). It also has been shown that expression of a dominant-
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negative mutant of GATA-3 in transgenic mice inhibited the production of IL-4, IL-5 and IL-13 
and inhibited airway inflammation in a murine model of asthma (Zhang, Yang et al. 1999)
.
 These 
observations indicate that GATA-3 might control the production of all Th2 specific cytokines 
and so maintains the Th2 phenotype. 
 It has been shown that the activation of STAT6:ER did not induce Th2-specific cytokines in 
committed Th1 cells (Kurata, Lee et al. 1999).  Although activated STAT6:ER could induce 
Th2-specific cytokines and repress IFN-γ production in developing Th1 cells, this effect rapidly 
decreased when the activation of STAT6 was delayed. As all the Th1 cells within the population 
differentiated the lack of effect upon delayed activation of STAT6 also correlated with a 
decreased level of induction of the Th2-specific transcription factors GATA-3 and c-Maf. 
Experiments have shown that cAMP enhanced the GATA-3 effects to induce IL-4 and IL-5, 
although it had no effect on inducing these cytokines in Th1 cells in isolation (Lee, Takemoto et 
al. 2000). 
It has been shown that cAMP (Cyclic adenosine monophosphate) levels are high in Th2 cells, 
and addition of cAMP as well as cAMP-elevating agents such as forskolin and PGE2 selectively 
upregulate Th2 cytokine production in Th2 clones, (reviewed by (Lee, Takemoto et al. 2000). 
Studies of the gene promoter for IL-5 have established independently the important roles of 
GATA-3 and cAMP in specific expression of the IL-5 gene in a transformed thymoma cell line 
EL-4 as well as Th2 clones (Lee, O'Garra et al. 1998). A GATA-3-binding site was identified in 
the regulatory sequences that lie within 1 Kbp (kilo base pairs) upstream of the IL-5 gene; four 
cis-acting elements including the GATA-3 binding site have been mapped. By contrast, a role for 
GATA-3 in the activation of the IL-4 promoter has not been clear. Transfection and expression 
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of GATA-3 was sufficient for transcription of the IL-5 but not the IL-4 promoter in spite of the 
presence of putative GATA-3 sites in the IL-4 promoter (Zhang, Yang et al. 1998). An antigen-
inducible GATA-3-binding enhancer was recently identified in the 39 flanking region of the IL-4 
gene by DNase I hypersensitivity analysis (Agarwal, Avni et al. 2000). These findings suggest 
that GATA-3 controls IL-4 expression through distal enhancer elements outside the IL-4 
promoter, possibly by mechanisms other than transactivation.  
1.1.8 Th1 and Th2 cytokine gene regulation at the chromatin level 
The regulatory elements in the Th2-specific gene cluster have been better defined than those in 
the Th1-specific gene cluster. Genes encoding IL-5, IL-13 and IL-4 are within the Th2 cytokine 
gene cluster in the long arm of human chromosome 5, q23–31, syntenic mouse chromosome 11, 
spreading over 160 Kbp. The deletion of this region, del (5q), is frequently observed in patients 
with a myelodysplastic syndrome.  Several reports have indicated that differentiation to Th2 cells 
is linked with changes in chromatin structure in the IL-4 gene locus but not in the IFN-γ locus 
(Agarwal and Rao 1998). The DNA within transcriptionally inactive genes is found in regions of 
condensed chromatin, contains unmodified histones and is often densely methylated 
(methylation is an epigenetic mechanism for silencing genes). However, histone acetylation and 
DNA demethylation favour decondensation of chromatin, which can be demonstrated by the 
sensitivity of sites in the DNA to cleavage by the enzyme DNase I (DNase I hypersensitive 
sites), and provide increased access to factors such as transcription factors. Five clusters of 
DNase I hypersensitive sites (I–V) have been mapped within a 19-Kb fragment, flanked by the 
restriction sites for the enzyme BamH1, spanning the IL-4 gene in a Th2 clone, D10, and are 
accompanied by CpG demethylation. By contrast, a Th1 clone, D5, exhibited a relatively 
34 
‗closed‘ chromatin structure, with only one hypersensitive site (IV)(Agarwal and Rao 1998). 
Similarly, differentiating Th2 cells rapidly acquired an accessible chromatin structure in the IL-
13 genes as well. In addition to these hypersensitive sites observed in the IL-4 gene, three 
additional DNase I hypersensitive sites have been identified (HSS1, 2 and 3) in an intergenic 
region between the IL-4 and IL-13 genes separated by 15 Kb, both in a Th2 clone and in 
differentiated Th2 cells. The appearance of HSS1 and HSS2 is specific to Th2 cells but is 
constitutive and independent of stimulation (Takemoto, Koyano-Nakagawa et al. 1998).  
Interestingly, the largest conserved noncoding sequence, CNS-1, was located in the intergenic 
region between IL-4 and IL-13, where the Th2-specific hypersensitive sites (HSS1 and HSS2) 
had been mapped previously. The biological properties of CNS-1 were characterized recently by 
establishing transgenic mice bearing a human YAC transgene (Loots, Locksley et al. 2000). 
Conditional deletion of the CNS-1 element in a 450-kb human transgene resulted in a decrease in 
the number of Th2 cells expressing human IL-4, IL-5 and IL-13. This indicates that CNS-1 
might contain a crucial sequence controlling all cytokine genes within the IL-4 locus. Their 
results also suggested that GATA-3 functions as more than a sequence-specific transactivator 
and plays a role as a master switch in Th2 development. 
Complementary changes in chromatin occur at the IFN-γ locus during Th1 commitment, but 
these are less well defined compared with those in Th2 cells. Specific DNase I hypersensitive 
sites were originally mapped in the IFN-γ gene. Further characterization of hypersensitive 
regions within the IFN-γ gene showed that Th1 cells developed these sites in the first and third 
introns during differentiation from a naive CD4
+
 T cell. In addition, the locus is hypomethylated 
in Th1 but not Th2 cells (Agarwal and Rao 1998). 
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So, GATA-3 and T-bet are major inducers of Th1 and Th2 differentiation by controlling the 
production of their respective cytokines. In addition they are involved in the commitment and 
stable maintenance of the Th1 and Th2 phenotypes. GATA-3 might function not only in 
transactivation of genes but also by inducing epigenetic changes in the chromatin structure of the 
IL-4 locus. 
There is a debate about whether the cytokines that induce Th1 or Th2 differentiation ‗instruct‘ 
the developmental fate of naive Th cells or ‗select‘ for cells which have already undergone a 
random process of gene activation and already produce a range of cytokines indicative of a Th1 
or Th2 cell (reviewed in (Coffman and Reiner 1999)). As discussed above, stable cytokine 
expression is accompanied by demethylation and increased chromatin accessibility of the 
cytokine genes and, in addition, chromatin accessibility is acquired after repeated stimulation 
under Th1 or Th2 conditions, which correlates with a committed Th phenotype.  
1.2 Regulation of T helper 17 differentiation 
Over the last two decades, our understanding of helper/effector T cell differentiation has changed 
dramatically, with the addition of new T helper subsets that preferentially produce distinct 
cytokines. One includes cells that selectively produce IL-17A and IL-17F (Th17 cells). These 
cells are critical for host defence against extracellular pathogens (Ye, Rodriguez et al. 2001) and 
have been implicated in a number of autoimmune diseases (Annunziato, Cosmi et al. 2009; 
Kyttaris, Zhang et al. 2010; Steinman 2010). Th17 cells have also been shown to produce IL-9, 
IL-10, IL-21, and IL-22; however, subsets of cells that selectively produce these cytokines have 
also been identified (Nurieva, Chung et al. 2008; Veldhoen, Uyttenhove et al. 2008). The other 
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major lineage of CD4
+
 T cells includes those that express the transcription factor Foxp3. These 
immunosuppressive, regulatory T (Treg) cells comprise both natural (n)Tregs and induced 
(i)Tregs. Th17 cells can mediate inflammatory responses and functionally oppose Treg cells. 
1.2.1 T cell receptor (TCR) signaling and IL-17 production 
Like Th1 and Th2 the obligate first step in the activation of CD4
+
T cells is engagement of the T 
cell receptor: this is an important contributor to IL-17 regulation. For naive CD4
+
 T cells, the 
strength of TCR signalling is an important driver of Th1 versus Th2 differentiation (Zhu and 
Paul 2008). Exactly how the signal strength influences IL-17 regulation is not completely 
understood. Recently it has been found that high dose antigen-loaded dendritic cells induce Th17 
generation (Iezzi, Sonderegger et al. 2009). The Tec family tyrosine kinase inducible T cell 
kinase (Itk) is a tyrosine kinase required for full TCR-induced phospholipase C-g activation.   
Itk
-/-
mice show decreased IL-17 production (Gomez-Rodriguez, Sahu et al. 2009). The same was 
seen with Raftlin, a protein located in lipid rafts, has been suggested to regulate the strength of 
TCR signaling. Raftlin
-/-
T cells produce less IL-17 and Raftlin
-/-
mice show reduced severity of 
experimental autoimmune encephalomyelitis (EAE) (Saeki, Fukuyama et al. 2009). The same 
has been found with an E3 ubiquitin ligase denoted GRAIL (gene related to anergy in 
lymphocytes) which regulates TCR-CD3 degradation and also influences IL-17 production 
(Nurieva, Zheng et al. 2010). These results are puzzling as these strong signals can induce T-bet 
expression and Th1 differentiation. In human CD4
+
 T cells, it has been shown that weak TCR 
stimulation promotes Th17 responses (Purvis, Stoop et al. 2010). This could be due to 
upregulation of T-bet which attenuates IL-17 production. 
37 
 Recent work has also shown that mammalian target of rapamycin (mTOR) complex 2 
(mTORC2) impaired differentiation into Th1 and Th2 cells without significant effect on Th17 
differentiation (Lee, Gudapati et al. 2010). 
Signals from co-stimulatory molecules are also important for T helper cell specification. But it is 
still not clear for Th17 differentiation; both Inducible T cell COStimualtor (ICOS) and CD28 
activation have been implicated in Th17 differentiation. ICOS
-/-
mice have exaggerated severity 
of Th17-mediated encephalomyelitis (Galicia, Kasran et al. 2009), while ICOS
-/-
CD4
+
 T cells 
show no significant increase of IL-17 production in vitro. More work is needed in this area. 
1.2.2 Role of cytokines in Th17 differentiation 
IL-23 is a heterodimeric cytokine composed of p19 and p40 subunits, with P40 subunit being 
shared with IL-12. IL-23 is a well-known inducer of IL-17. Studies have shown that gene 
targeting of p19 dramatically attenuated EAE, a disease that is dominated by Th cells that 
produce IL-17 (Cua, Sherlock et al. 2003). However, recently it has been shown that naive T 
cells do not express the IL-23R and that it needs to be induced (Zhou, Ivanov et al. 2007). This 
has led to the idea that IL-23 cannot be the sole inducer of Th17 differentiation. Cytokines such 
as IL-6 and IL-21 are implicated in the regulation and induction of IL-17 production. In vitro, IL-
6 is a potent inducer of Th17 cells but only when combined with other cytokines including 
transforming growth factor β1 (TGF-b1). This led to the finding that both cytokines TGF-β1 and 
IL-6 are needed as the initial driver of Th17 specification (see Figure 1-5). However, IL-6
-/- 
mice 
have reduced numbers of Th17 cells (Mangan, Harrington et al. 2006), suggesting that in vivo 
other cytokines can compensate for its actions. One candidate cytokine is IL-21, which is 
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produced by Th17 and follicular helper T cells (Tfh). IL-21 induces IL-17, itself and can also 
induce the expression of IL-23R (Veldhoen, Hocking et al. 2006; Korn, Bettelli et al. 2007). 
However, in disease models that depend on Th17 specification, IL-6 seems to be more relevant 
than IL-21. Studies looking at cytokine specific KO mice to IL-6 or IL-21 show them to be 
protective from EAE. Other studies have shown that the development of EAE was not impaired 
by the absence of IL-21 signals (Coquet, Chakravarti et al. 2008; Sonderegger, Kisielow et al. 
2008). Suggesting that both IL-6 and IL-21 can promote Th17 differentiation, but neither appears 
to be very necessary in vivo. 
 The combination of TGF-β and IL-6 is a very effective for inducing naive T cells to become IL-
17 producers. Consistent with this idea is that deleting TGF-β has also been reported to inhibit 
Th17 differentiation in vivo. In addition, transgenic overexpression of TGF-β in T cells was 
associated with increased susceptibility to the development of EAE in mice injected with MOG 
peptide (Bettelli, Carrier et al. 2006).  It has been reported recently that the downstream signals 
of TGF-β and Smad2 are important for TGF-β mediated Th17 cell generation (Malhotra, 
Robertson et al. 2010; Martinez, Zhang et al. 2010).  Smad2
-/-
mice showed less severe disease in 
an EAE model (Takimoto, Wakabayashi et al. 2010). It has also been shown that CD4
+ 
T cells 
that lack the molecular adaptor tumour necrosis factor receptor associated factor 6 (TRAF6) are 
more sensitive to TGF-β induced Smad2/3 activation and also exhibit a specific increase in Th17 
differentiation (Cejas, Walsh et al. 2010). 
However, findings have shown it is not that easy to input a role for TGF-β as an inductive factor 
in Th17 differentiation and it is complicated by the fact that mice lacking this cytokine or its 
receptor subunits develop a fatal systemic autoimmune disease. So the mechanism by which 
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TGF-β induces Th17 development still is not clear. An essential role of TGF-β in Th17 
differentiation has recently been challenged by Das and Ren et al. They show that in mutant T 
cells lacking T-bet and STAT6, IL-6 alone was found to be sufficient to generate Th17 cells 
(Das, Ren et al. 2009). This suggests that TGF-β plays an indirect role in Th17 differentiation by 
suppressing the expression of T-bet and GATA3, and limiting differentiation to alternate fates. 
 
Figure 1-5 Cytokines involved with Th17 differentiation. (Modified from Korn amd Bettelli 2009) 
Naïve T cells differentiate to Th17 cells in the presence of TGF-β and cytokines from innate immune cells 
(APCs) which lead to production of pro inflammatory cytokines IL-17A, IL-17F and also IL21 and IL-22. 
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1.2.3 Th17 and Treg paradigm 
In addition to effector T cells there is another subset of novel CD4
+
 T cells that regulate Th cells 
termed T regulatory cells (Tregs). They are essential for dominant immunological tolerance. 
Surprisingly, both Th17 and Treg cells can develop from naive CD4
+
 T cell precursors under the 
influence of the same cytokine, transforming growth factor β1 (TGFβ1), (see figure 1-5). 
FOXP3
+
CD25
+
CD4
+ 
Treg cells have the ability to suppress the proliferation and function of 
other immune and non-immune cells including T effector cells (Teff cells), B cells, macrophages 
and dendritic cells (DCs). So far, at least two types of FOXP3
+ 
Treg cells, including naturally 
occurring Treg (n Treg) and inducible Treg (iTreg) have been identified. 
Thymic-derived  nTreg cells are constantly expressing FOXP3, and comprise nearly 10% of total 
peripheral CD4
+
 T cells in mice and humans. nTreg cells function as immune suppressors and 
express high levels of FOXP3, which play a crucial role in the maintenance of self-tolerance and 
immune homeostasis. Genetic mutations of the forkhead box transcription factor FOXP3 leads to 
lethal X-linked syndrome ―Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked 
Syndrome‖ (IPEX) in humans, and the scurfy (sf) phenotype in mice, which is usually 
accompanied by multiple immunopathologies including type I diabetes, inflammatory bowel 
disease as well as massive lymphocytic infiltrates.  
iTregs are induced in the periphery by immune suppressive cytokines such as TGF-β after TCR 
stimulation (Chen, Jin et al. 2003). Other iTregs include Tr1 and Th3 cells. Tr1 cells often locate 
in the intestinal mucosa and so far no specific surface marker for Tr1 cells has been identified; 
Foxp3 gene expression cannot be constitutively induced in iTregs, and they highly express 
immune suppressive cytokines including IL-10 and TGF-β, showing that Tr1 cells are a subset of 
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Treg rather dissimilar from nTreg. Th3 cells are induced primarily from naive CD4
+
 T cells and 
have been shown to have regulatory function in oral tolerance (Chen, Kuchroo et al. 1994). Th3 
cells highly express TGF-β, and may also express Foxp3, so they cannot be identified as a 
distinct subpopulation of iTreg or as an activated nTreg cells. Both nTreg and iTreg cells have 
the ability to suppress the function of T effector cells and in maintaining host immune 
homeostasis. Recently, a CD8
+
 regulatory T cell lineage was reported to be essential for self-
tolerance. These CD8
+
 Treg cells target Qa-1
+
 follicular T helper cells and suppress lethal 
systemic-lupus-erythematosus-like autoimmune disease (Kim, Verbinnen et al. 2010). 
The differentiation of Th17 and inducible Tregs (iTreg) from naive T cells depends on the level 
of TGF-β expression. See Figure 1- (Chen, Li et al 2010). A low level of TGF-β, IL23 or IL6 
induces naive T cells to develop into Th17 cells (Zhou, Chong et al. 2009). High levels of TGF-β 
in the tissue microenvironment can lead to the development of iTreg (Zhou, Lopes et al. 2008). 
Loss of the balance between Th17 and Treg cells in favour of the former will break immune 
homeostasis in the host and lead to the development of autoimmune diseases. Moreover, 
FOXP3
+
 Treg cells are not terminally differentiated cells, and can also redifferentiate into a 
variety of T effector cells including Th17 cells, Tfh cells, as well as autoaggressive and 
pathogenic memory T cells in vivo after losing FOXP3 expression under certain inflammatory 
conditions. Researchers have found that a significant number of CD4
+
FOXP3
+
 Treg cells in 
human peripheral blood and lymphoid tissue which express CCR6 (chemokine (C–C motif) 
receptor 6) can develop into Th17 cells with the capacity to produce IL-17 on mucosal sites 
during inflammation (Voo, Wang et al. 2009). Zhou and colleagues also found that a subset of 
Treg cells that lost Foxp3 expression and suppression function, named  exTreg, could produce 
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IL2 and IFN-γ instead of CD25, GITR, and CTLA-4; consequently, these exTreg cells act as 
effector T cells rather than the conventional suppressors (Zhou, Bailey-Bucktrout et al. 2009). 
 
Figure 1-6. TGF-β mediated regulation of the differentiation and function of Th17 and iTreg cells 
From Chen, Li et al. 2010. TGF-β orchestrates Th17 and Treg cell differentiation in a content 
and concentration dependent manner. Low concentration of TGF-β stimulation in cooperation 
with IL-6 and IL-21 favor the differentiation of Th17, whereas it is favourable towards the 
differentiation of Treg cells under high concentration of TGF-β that represses IL-23R 
expression. 
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1.2.4 IL-1 and Th17 
The inflammatory cytokine, IL-1 has a new role with the recognition that it is a major promoter 
of Th17 development in both mouse and humans, synergizing with IL-6 and IL-23. Studies have 
shown that IL1R
-/-
CD4
+
 T cells are severely impaired to differentiate towards Th17 cells in vivo 
and IL1R
-/-
 mice show reduced incidence of EAE (Ben-Sasson, Hu-Li et al. 2009). Also, gamma 
delta (gd) T cells activated by IL-1b and IL-23 have been found to produce IL-17, IL-21 and IL-
22 (Sutton, Lalor et al. 2009). The IL-1R has homology to Toll-like receptors (TLR), and IL-1 
engagement of its receptor results in the recruitment of the adapter MyD88 and IL-1 receptor-
associated kinases (IRAK). A recent study has indicated that single Ig IL-1R-related molecule 
(SIGIRR), a negative regulator of IL-1R and TLR signalling, controls Th17 cell differentiation 
and proliferation. The study also showed that IL-1-induced Th17 cell expansion is dependent on 
mTOR (Gulen, Kang et al. 2010). 
1.2.5 Regulation of IL-17 production by G-protein coupled receptors 
Studies have shown that the addition of S1P (abundant lysophospholipid present in blood and 
lymph) to cultures of splenic CD4
+ 
T cells has increased IL-17 and reduced IFN-γ and IL-4 
production (Liao, Huang et al. 2007). S1P signals via a G-protein coupled receptor (GPCR) 
known as S1PR1. S1P regulates T cell trafficking. Transgenic overexpression of an S1P receptor 
resulted in enhanced IL-17 production. Prostaglandins are another group of lipids that signal via 
GPCR. During inflammation, prostaglandin E2 (PGE2) is highly induced. Interestingly, culture 
of human peripheral blood mononuclear cells with PGE2 and IL-23 resulted in high levels of 
production of IL-17 and chemokine ligand CCL20, with less IFN-γ and IL-22 (Chizzolini, 
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Chicheportiche et al. 2008). PGE2 acts through prostaglandins EP2- and EP4-mediated 
signalling and cyclic AMP pathways to upregulate IL-23Rand IL-1R expression resulting in 
synergistic induction of Th17 cells with IL-23 and IL-1b (Boniface, Bak-Jensen et al. 2009). In 
vivo administration of PGE2 induced IL-23-dependent IL-17 production and exacerbated 
collagen-induced arthritis (CIA) in mice (Sheibanie, Khayrullina et al. 2007). 
1.2.6 Regulation of Th17 differentiation by transcription factors 
1.2.6.1 STAT3 in Th17 differentiation 
Cytokines exert their effects through signal tranducers and activators of transcription 
(STATs).The major cytokines that induce IL-17, IL-23, IL-6 and IL-21 all activate STAT3. The 
critical role of STAT3 was established by the finding that deletion of STAT3 in T cells abrogated 
Th17 differentiation (Yang, Panopoulos et al. 2007). It has been found that retroviral 
overexpression of constitutively active STAT3 was sufficient to induce IL-17 production 
(Mathur, Chang et al. 2007). Importantly, conditional deficiency of STAT3 in CD4
+
 T cells 
impairs IL-17 production in vivo and limits IL-17-associated pathology. Patients with Hyper IgE 
syndrome (HIES) (a primary immunodeficiency disorder, due to dominant negative mutations of 
STAT3) had severely impaired ability to produce Th17 cells (Holland, DeLeo et al. 2007; 
Renner, Rylaarsdam et al. 2008). This shows that there is a requirement for STAT3 in human IL-
17 production. The impairment of STAT3 signalling and consequently attenuated Th17 
generation may explain the patient‘s inability to clear bacterial and fungal infections. 
STAT3 was initially found to directly bind to the IL-17 promoter by using chromatin 
immunoprecipitation (ChIP) assays. However, new technology, mostly ChIP and massive 
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parallel sequencing (ChIP-seq) provides the ability to define the function of transcription factors 
on a genome-wide scale (Park 2009). 
The functional relevance of the binding can be found by genome-wide transcriptional profiling 
and by assessing the transcription factor-dependent changes in epigenetic modifications. This has 
been done for STAT3 in Th17 cells and it was found that STAT3 binds many promoters and 
enhancers of genes involved in Th17 development. STAT3 binds throughout the IL-17A and IL-
17F locus. Interestingly, its binding is not restricted just within the promoter regions, STAT3 
also binds the intergenic region (see figure 1-7). STAT3 binds and regulates IL21, IL21r and 
IL23r genes. Importantly, STAT3 directly controls expression of many of the other transcription 
factors that participate in Th17 differentiation including RORγt, IRF4, and Batf. Interestingly, 
STAT3 has also shown to play a role in proliferation and survival of Th17 cells (Durant, Watford 
et al. 2010) and is important for both the expression of IL-23R and the downstream signalling of 
this cytokine receptor complex. 
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Figure 1-7. STAT3, BATF and RORγt binding sites in the IL17A/IL17F locus 
From K. Hirahara et al, 2010. STAT3 have been found to bind strongly with multiple conserved 
non-coding sequences located in the intergenic region between IL17A and IL17F. Binding sites 
of BATF and RORγt have been reported by others. The significance of those individual binding 
sites is of interest for further investigations. 
 
 
1.2.6.2 Retinoid receptors and Th17 cells 
7Retinoid receptors are a family of nuclear receptors and are part of a larger family of steroid 
nuclear receptors that have direct transcription factor properties. Retinoid receptors can be 
divided into three families: classical retinoic acid receptors (RARα–γ), retinoid X receptors 
(RXRα–γ) and the retinoic acid orphan receptors (RORα–γ). RORγt is a splice variant of the 
Rorc gene that results from initiation by a distinct promoter within the full length of the Rorc 
gene. This results in products that differ in their amino terminus (Jetten 2009). Whereas RORγ is 
ubiquitously expressed, a transcript known as RORγt is exclusively expressed in lymphoid cells. 
RORγt is critical for T cell development and lymphoid organogenesis. This is evident by the fact 
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that Rorc
-/-
mice exhibit reduced numbers of CD4
+ 
single-positive and double positive 
thymocytes. Rorc
-/-
 mice also lack lymphnodes, lymphoid tissue inducer cells and Peyer‘s 
patches. Rorc
-/-
mice also have shown to have reduced Th17 differentiation and have reduced 
disease severity in the EAE model (Ivanov 2006). The opposite has been found with the 
overexpression of RORγt, promotes IL-17 expression. In this way RORγt acts similarly to 
transcription factors such as T-bet and GATA3 in Th1 and Th2 differentiation, respectively, and 
so has been proposed to be a master regulator for Th17 differentiation. A number of multiple 
RORγt binding sites are present in the IL-17 promoter, and by the use of ChIP, RORγt has been 
found to bind the IL-17 gene (Ichiyama, Yoshida et al. 2008).  STAT3 binds the Rorc gene and 
studies have shown that STAT3-deficient T cells have poor expression of RORγt. However, 
overexpression of active STAT3 in Rorc
-/-
cells resulted in poor IL-17 induction (Ivanov 2006), 
arguing that STAT3 is necessary but not sufficient for IL-17 expression. Rather, STAT3 and 
RORγt appear to act cooperatively on the IL-17 locus to drive production of this cytokine 
(Figure 1-7). RORα, is another related retinoic acid nuclear receptor, and is preferentially 
expressed in Th17 cells. In contrast to RORγt, deletion of RORα had little effect on IL-17 
production. However, deficiency of both RORα and Rorc completely abolished IL-17 production 
and protected against EAE (Yang, Pappu et al. 2008). Interestingly co-expression of the RORα 
and Rorc enhanced the number of IL-17-producing cells. 
1.2.6.3 IRF4 and Th17 differentiation 
IRF4 is a member of the interferon regulatory factor (IRF) family of transcription factors and 
was originally thought to be a key inducer of GATA3 expression in Th2  differentiation. While, 
studies have shown IRF4-deficient T cells to impair IL-17 production in response to TGF-β and 
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IL-6. Recently, it has been shown that phosphorylation of IRF4 regulates IL-17 and IL-21 
production (Biswas, Gupta et al. 2010). Also, IRF4-deficient mice are resistant to EAE. It has 
also been seen that IRF4-deficientT cells fail to upregulate RORγt expression and differentiate 
into Th17 cells. Overexpression of RORγt in such T cells could not restore IL-17 production. It 
has been suggested IRF4 might co-operate with STAT3 to induce RORγt expression, but IRF4 
also interacts with NFATc1 and c2 (Hu, Jang et al. 2002). So in this way, it can affect other Th 
cell lineages. It is a rare example of a factor required for both Th17 and Th2 development, which 
is in contrast with the previously accepted links with Th17 and Th1 development via IL-23 
(Harrington, Hatton et al. 2005) and Th17 and Treg development via TGF-β (Bettelli, Carrier et 
al. 2006). 
1.2.6.4 Batf and Th17 differentiation 
Basic leucine zipper transcription factor, ATF-like (Batf) is a member of the AP-1 transcription 
factor family. It contains a basic region and leucine zipper, lacks a transcriptional activation 
domain and so has been considered as an inhibitor of AP-1 transcriptional activity. Recently, it 
has been shown that Batf is essential for Th17 cell differentiation (Schraml, Hildner et al. 2009). 
Mice lacking Batf fail to induce RORγt, and fail to express Th17 specific cytokines. Batf not 
only controls Th17 development through regulating RORγt expression, but also directly controls 
Th17 specific gene targets, since reconstitution of Batf 
-/- 
T cells with RORγt fails to restore IL-
17 expression. Observations consistent with this show that Batf directly binds to regulatory 
regions surrounding the IL-17 gene locus and the mechanism of gene regulation by Batf appears 
to arise from the formation of a heterodimer with Jun proteins that exerts transcriptionally unique 
actions on genes involved in the Th17 development. Batf binds to the promoters of IL-17, IL-
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17F, IL-21 and IL-22 (figure 1-8) and the intergenic regions between IL-17 and IL-17f (figure 1-
7). Studies by Schraml and his group have shown that immunization of Batf 
-/-
 mice with MOG 
peptide fails to induce EAE in contrast to wild-type mice, which is consistent with a requirement 
for Th17 development in EAE. This defect is due to a T cell intrinsic property of Batf 
-/-
T cells, 
since wild-type T cells transferred into Batf 
-/- 
mice restores the ability to manifest severe EAE 
after MOG immunization. However, Batf mRNA is not exclusively expressed in Th17 cells and 
it has been shown to be expressed in Th1 and Th2 cells and in activated B cells, with the 
development of Th1 and Th2 cells, mature B cells and all dendritic cell subsets being normal in 
Batf 
-/-
 mice. More recently, work by Murphy and his group has shown that Batf–Jun family 
protein complexes cooperate with IRF4 in binding to AP1–IRF composite elements (AICEs) in 
pre-activated CD4
+
 T cells stimulated with IL-21 and in Th17 differentiated cells. Importantly, 
Batf binding was diminished in IRF4
−/−
 T cells and IRF4 binding was diminished in Batf
−/−
 T 
cells, consistent with functional cooperation between these factors. It was also shown that AP1 
and IRF complexes cooperatively promote transcription of the IL-10 gene, which is expressed in 
Th17 cells and regulated by IL-21. These findings reveal that IRF4 can signal via AP1 motifs 
and so indicating new approaches for modulating IRF4-dependent transcription (Murphy, 
Tussiwand et al. 2013). 
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Figure 1-8 Batf regulates Th17 cell generation ( Martinez and Dong 2009). 
Batf is selectively required for Th17 cell induction. Whether T cell receptor (TCR) signaling or 
costimulatory molecules induce Batf expression is still unknown. Batf binds to IL-17A and IL-17F 
intergenic regions and IL-21 and IL-22 promoter regions, and induce Th17 cytokine production. Batf 
synergizes with RORγt in the induction of IL-17 expression. However, whether it also synergizes with 
RORα, Ahr and IRF4 in induction of IL-17, IL-22 and IL-21, respectively, needs to be further 
investigated. Moreover, Batf seems to be responsible for maintenance of RORγt expression, although the 
exact mechanism is unkown. 
 
 
 
1.2.6.5 Runx transcription factors 
Another crucial family of proteins that regulate CD4
+
 T helper cell differentiation are Runx 
transcription factors. There are three mammalian Runx domain transcription factors: Runx1, 
Runx2, and Runx3. Runx1 is important for normal haematopoiesis, which includes thymic T cell 
development (Collins, Littman et al. 2009). Additionally, both Runx1 and Runx3 are reported to 
act as repressors of CD4 and Zbtb7b (the latter being encodes Th-POK, a transcription factor that 
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regulates CD4
+ 
differentiation), but at different stages of thymocyte development to affect the 
CD4/CD8 lineage choice (Setoguchi, Tachibana et al. 2008; Collins, Littman et al. 2009). In 
CD8
+
 T cells Runx3 functions as a CD4 silencer and is involved in a feed-forward regulatory 
circuit in which T-bet induces Runx3 and then joins with Runx3 to direct activation of IFN-γ and 
silencing of IL-4 (Djuretic, Levanon et al. 2007). In Treg cells, Runx1 binds the N-terminus of 
Foxp3. This interaction is required for Foxp3 mediated suppression of IL-2 production and 
suppression activity of Treg cells. Recent work has shown that Runx1 also plays a role in Th17 
differentiation (Zhang, Meng et al. 2008). Both Runx1 and RORγt bind to the IL-17 promoters 
and, by interaction with distinct functional partners (RORγt versus FOXP3), Runx1 may 
contribute to both Treg and Th17 differentiation. 
1.2.6.6 Aryl hydrocarbon receptor 
The aryl hydrocarbon receptor (AHR) is highly conserved in evolution and belongs to a bHLH-
PAS family of transcription factors. AHR senses a wide range of small synthetic compounds and 
natural ligands. Importantly, environmental toxins such 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) bind AHR. Upon ligand binding in the cytosol, AHR undergoes conformational change, 
translocates to the nucleus and dissociates with its chaperone Hsp90 and p23. Th17 cells 
preferentially express AHR and tryptophan-derivedphotoproduct 6-formylindolo [3,2-b] 
carbazole (FICZ), promote expression of IL-17, IL-17F and IL-22. It has been shown that Th17 
cells and also gd T cells express AHR (Martin, Hirota et al. 2009). Mice lacking AHR have 
reduced severity in EAE; however, AHR is important for IL-22 but not IL-17 production 
(Veldhoen, Hirota et al. 2008). TCDD is very immunosuppressive and activation of AHR by 
TCDD expands CD25
+
 FOXP3
+
Treg cells, which suppress EAE (Quintana, Basso et al. 2008). 
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Recent work has indicated that activation of AHR also induces FOXP3
+ 
Treg cells in humans 
(Gandhi, Kumar et al. 2010). How different AHR agonists seem to have distinct effects is 
puzzling; however, AHR expression in Th17 cells provides a link as to how environmental 
toxins might contribute to the pathogenesis of autoimmune diseases. 
1.2.6.7 Nuclear factor of activated T cells and NF-kB family 
As a result of TCR ligation there are elevated levels of intracellular Ca2
+
, which leads to the 
dephosphorylation and activation of members of the nuclear factor of activated T cells (NFAT) 
transcription factor family. The proximal promoter of the human and mouse IL-17 genes contain 
multiple NFAT binding sites. Recently, it has been shown that CD4
+
 T cells expressing 
hyperactivable NFAT1 produce more IL-17 (Ghosh, Koralov et al. 2010). Also, proteins that 
interfere with the DNA binding of NFAT can regulate IL-17 expression. It has been 
demonstrated that NR2F6, a nuclear zinc-finger orphan receptor, acts as a transcriptional 
repressor of Th17 cells, similar to zinc-finger proteins that repress GATA3 and Th2 cells 
(Hermann-Kleiter, Gruber et al. 2008). IL-1, a major promoter of Th17 development, activates 
NF-kB. A recent study has shown that the NF-kB family member IkBz regulates Th17 
development by cooperating with ROR nuclear receptors (Okamoto, Iwai et al. 2010). Another 
member of the NF-kB family, c-Rel is also shown to play a critical role in the differentiation of 
Th17 cells (Chen, Hardy et al. 2010). 
1.2.6.8 Negative regulation of Th17 differentiation 
In addition to positive roles in regulating Th17 differentiation, cytokines that bind cytokine 
receptors can negatively regulate Th17 differentiation. STATs are not necessarily differentially 
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expressed among subsets. Cytokine receptor expression can be down modulated, but the action 
of STATs can be redundant. Consistent with work indicating that IFN-γ and IL-4 also antagonize 
Th2 and Th1 differentiation, respectively, IFN-γ and IL-4 also inhibit IL-17 production. IL-27 is 
an IL-12-related cytokine that consists of two subunits, p28 and EBI3 (Pflanz, Timans et al. 
2002). Like the IL-6R, the IL-27R complex contains gp130, but in addition it also has a ligand-
specific subunit named WSX-1. Even though there are similarities to IL-6, IL-27 has the 
opposite effect in regulating IL-17 expression; it is a critical negative regulator of Th17 
differentiation (Batten, Li et al. 2006). Like IFN-γ, IL-27 activates STAT1 and the inhibitory 
effect of IL-27 on Th17 differentiation is abrogated in STAT1-deficient mice. Activated by IL-
12, STAT4 is well known as a critical positive regulator of Th1 differentiation and IFN-γ 
production. As both IL-12 and IFN-γ suppress IL-17 production, it would be expected that 
STAT4 would negatively regulate IL- 17 expression. However, two studies have reported that 
IL-17 production is decreased in STAT4-deficient T cells, suggesting a positive role of STAT4 
for IL-17 production (Hildner, Schirmacher et al. 2007; Mathur, Chang et al. 2007). The 
decreased IL-17 production in STAT4-deficient T cells might be related to the impaired IL-23 
signalling, as IL-23 has been shown to activate STAT4 (Watford, Hissong et al. 2004). IL-2 is a 
well-known T cell growth factor in vitro, but at the same time the deficiency of IL-2 results in 
severe multi-organ autoimmune disease in vivo (Malek 2008). This is in part due to its role in 
promoting the differentiation of Tregs by STAT5, but recent work has shown that IL-2 also 
suppresses Th17 differentiation in a STAT5-dependent manner. Like IL2
-/-
mice, STAT5-
deficient mice suffer from inflammatory autoimmune disease that is associated with a loss of 
Treg cells and the simultaneous expansion of Th17 cells. STAT5a/b appear to be essential for 
FOXP3 expression and in constraining Th17 cells (Laurence, Tato et al. 2007; Yao, Kanno et al. 
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2007). However, the mechanisms underlying the blockade of Th17 differentiation by IL-2 via 
STAT5 are not clear. One possibility could be that it is mediated indirectly via induction of 
FOXP3, a factor known to bind and inhibit RORγt. Alternatively, STAT5a/b might act as a direct 
repressor to inhibit IL-17a expression. Negative regulation of Th17 by nuclear receptors is in 
contrast to RORγt and RORγ, other retinoic acid nuclear receptors have been suggested to inhibit 
Th17 differentiation. Several groups have shown that retinoic acid inhibits Th1, Th2 and Th17 
differentiation in vitro. Retinoic acid down regulates expression of RORγt and enhances the 
expression of FOXP3 (Mucida, Park et al. 2007; Elias, Laurence et al. 2008)., and an RAR 
antagonist inhibited FOXP33 expression. FOXP3 binds to the Il17 promoter and so FOXP3 and 
RORγt, directly interact and modify each other‘s function.  
Peroxisome proliferator-activated receptor γ (PPARγ) is a member of the nuclear receptor 
superfamily of transcription factors. There have been a number of natural and synthetic PPARγ 
ligands have been described to exert anti-inflammatory effects on various levels. Upon ligand 
binding, PPARγ translocates into the nucleus and forms a heterodimer with the retinoid X 
receptor and then binds to PPARγ response elements located in the promoter region of target 
genes. Recently the relevance of PPARγ in Th17 differentiation has been demonstrated with the 
use of the synthetic ligand, pioglitazone (PIO) (Klotz, Burgdorf et al. 2009). Th17 differentiation 
and expression of Th17-assocated genes (Il23r, Il21, Il17 and Il17f) were dramatically inhibited 
by treatment of CD4
+
 T cells with PIO, but this had no effect on Th1 differentiation. PIO 
ameliorated EAE clinical scores and mice had fewer IL-17 producing cells in the CNS. 
Consistent with this, the mice lacking PPARγ in CD4+ T cells showed earlier onset and 
aggravated disease in the initial T cell dependent phase of EAE. However, there was no 
difference in the later effector phase of disease. 
55 
1.2.7 Socs3 
Suppressor of cytokine signalling (Socs3) is a cytokine-inducible negative regulator of STAT3; 
Socs proteins are among the most prominent Stat-regulated genes providing a negative feedback 
to STAT signalling. It was first shown that T cell-specific deletion of Socs3 is associated with 
enhanced STAT3 phosphorylation and increased IL-17 levels (Chen, Laurence et al. 2006). 
Deletion of Socs3 in endothelial and hematopoietic cell compartment is associated with 
widespread autoimmune disease and also increased susceptibility to both CIA and EAE (Wong, 
Egan et al. 2006). 
 
1.2.8 MicroRNA and negative regulation of IL-17 
MicroRNAs (miRNAs) are a large family of post transcriptional regulators of gene expression 
that are approximately 21 nucleotides in length. Dicer is an RNaselll-like enzyme that is required 
for generating miRNAs. Specific deletion of Dicer in T cells resulted in impaired T cell 
development and aberrant IFN-γ production (Muljo, Ansel et al. 2005). Ets-1 is a transcription 
factor that associates with T-bet and binds the IFN-γ promoter. Ets-1 deficiency results in 
enhanced Th17 differentiation, along with increased levels of mRNA for IL-22 and IL-23R. Ets-
1‘s actions are likely to be indirect, as no binding of Ets-1 to the promoter of IL17 was seen. 
Studies have shown that Ets-1 appears to negatively regulate Th17 differentiation through effects 
on IL-2. Specifically, Ets-1-deficient T cells were found to secrete less IL-2 and have impaired 
responsiveness to this cytokine. Ets-1 has been found to be a target of microRNA mir-326 and 
mir-326 has been reported to be upregulated in patients with multiple sclerosis and in murine 
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Th17 cells generated in vitro (Du, Liu et al. 2009). Overexpression of mir-326 enhances Th17 
generation and disease severity in EAE whereas blocking mir-326 reduces Th17 generation and 
ameliorates disease severity of the EAE. This has been explained by regulating expression of 
Ets-1. Recently, miRNAs, mRNA, and ChIP-seq were performed to characterize the 
microRNome during lymphopoiesis within the context of the transcriptome and epigenome 
(Kuchen, Resch et al. 2010). The authors showed that H3K27me3 inhibited expression of 
induced miRNAs during lymphopoiesis. These studies reveal some of the epigenetic, 
transcriptional, and post transcriptional strategies that help orchestrate cellular abundance of 
miRNAs during lymphopoiesis. 
 
1.2.9 Relationship of Th17 cells to other subsets: influence of epigenetic 
modification 
Cellular differentiation is associated with heritable changes in chromatin in daughter cells that 
preserve gene expression. Epigenetic modifications such as DNA methylation, chromatin 
remodelling, histone modifications and incorporation of histone variants can all contribute to 
regulate gene expression. Cytokine genes in Th cell subsets are similarly regulated. The IL-17 
gene is linked to the IL-17F gene on chromosome 1 (human histone marks are STAT3-
dependent). Some of STAT3 binding sites are shared with p300 binding. Although the classic 
model of Th1 and Th2 differentiation suggests that these subsets behave like terminally 
differentiated cells, recent findings indicate more flexibility than first noted and recent findings 
provide mechanisms for flexibility in expression of key transcription factors. While the histone 
methylation at the proximal promoters of cytokines genes showed reciprocal permissive 
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(H3K4me3) and repressive (H3K27me3) marks in cell subsets that express the signature 
cytokines, the histone methylation patterns of the key transcriptional factors for lineage 
specification exhibit bivalent modifications of those genes are not expressed. For example, the 
promoters of Tbx21 and Gata3 are modified by both H3K4me3 and H3K27me3 in Th17 cells, 
suggesting that these genes are set up for expression. This is consistent with the reported 
transition of Th2 to produce IFN-γ following viral infection (Ghoreschi, Laurence et al. 2010).  
 
1.2.10 Th17 cells in health and disease 
The Th17 subset exhibits effector T cell function distinct from Th1 and Th2 cells and has been 
identified as an important mediator of autoimmune disorders (Steinman 2007). Th17 cells were 
characterized due to producing the cytokine IL-17. The IL-17 cytokine family contains six 
members, which include IL-17A, IL-17B, IL-17C, IL-17D, IL-17E (i.e. IL-25) and IL-17F. IL-
17 cytokines promote tissue inflammation via the induction of other pro-inflammatory cytokines 
and chemokines (Korn, Bettelli et al. 2009). Increased IL-17 levels have been detected in 
multiple autoimmune models in animals, as well as in human patients with various autoimmune 
disease syndromes, such as systemic lupus erythematosus, multiple sclerosis, inflammatory 
colitis, rheumatoid arthritis and psoriasis. In rheumatoid arthritis, Th17 cells may induce matrix 
metalloproteases and stimulate osteoclasts, which leads to the development of cartilage and bone 
destruction. IL-17 deficient mice or mice treated with an IL-17 receptor antagonist are resistant 
to the development of arthritis. Similarly, IL-17 deficient mice display delayed onset and 
reduced severity of experimental autoimmune encephalomyelitis (EAE). Evidence also showed 
that Th17 cells were involved in the pathogenesis of colitis and are capable of inducing EAE 
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when adoptively transferred into naive wild-type mice. In chronic inflammatory bowel disease, 
Th17 cells seem to be essential for inducing the breakdown of intestinal epithelial barriers. Once 
induced, Th17 cells drive immunopathology and tissue inflammation in vivo. These data all 
support the notion that IL-17-producing Th17 cells play an important role in the induction and 
propagation of autoimmune diseases.  
The IL-23/Th17 axis has a strong impact on the pathogenicity of autoimmune diseases. IL-23 
was shown to promote the production of IL-17 by activated T cells and IL-23 expanded T cells 
are able to transfer EAE and CIA (Langrish, Chen et al. 2005). Th17 cells cannot maintain their 
immune features without IL-23 in vivo and in vitro. IL-23 may not be involved in the initial steps 
of driving the differentiation of naive T cells into Th17 cells. Similar to IL-12 for Th1 cells, IL-
23 plays a fundamental role in stabilizing the Th17 lineage and expanding Th17 responses. IL-23 
also induces proinflammatory effector cytokines in Th17 cells. Therapeutic neutralization of IL-
23 can prevent EAE relapses and decrease the expression level of IL-17 in the central nervous 
system (Gran, Zhang et al. 2002). Thus, IL-23 is essential for full differentiation and exhibiting 
of effector function by Th17 cells. 
Th17 cells are now identified as potent inducers of autoimmunity, while Th1 cells have been 
well studied in induction and development of organ-specific autoimmune diseases. Th1 cells 
commonly found present along with Th17 cells in inflamed tissues, but the interaction between 
Th1 and Th17 cells during autoimmune disease is still unclear. Recent work indicated that Th17 
cells might cross-regulate Th1 development in intestinal inflammation, in which IL-17 cytokine 
could mediate a protective effect (O'Connor, Kamanaka et al. 2009). These researchers 
demonstrate that IL-17 could suppress the expression of T-bet, osteopontin as well as the IL-
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12β2 receptor to inhibit the development of Th1 cells. The mechanism underlying how IL-17 and 
Th17 cells cross-regulate other T cell subsets remains unclear. 
1.3 Early growth response family 
Early growth response (Egr) family comprises four members: Egr-1, Egr-2 (Krox-20), Egr-3 
(Pilot) and Egr-4 (NGFI-C). The most closely related members are Egr-2 and Egr-3, followed by 
Egr-1. Egr-4 is much more distant. Several conserved sequences have been noted between all 
members: the zinc fingers and two basic regions flanking the zinc fingers are conserved between 
Egr-1, Egr-2 and Egr-3, the C-terminal one being also observed in Egr4; the Nab interaction 
domains present in Egr-1, Egr-2 and Egr-3 (Poirier, Cheval et al. 2008). They encode closely 
related transcription factors that contain three Cys2-Hys2 zinc fingers shared by the four 
members and can bind to the same GC-rich consensus DNA binding motif, the Egr response 
element (ERE). There is high homology between the three zinc finger sequences of the four 
members of the Egr family (Beckmann and Wilce 1997) suggesting that the proteins can bind to 
cis-regulatory regions of at least a subset of the same target genes (Chavrier, Vesque et al. 1990; 
Swirnoff and Milbrandt 1995). However, outside their common DNA-binding domain, the 
sequences of the different Egr members have less homology, suggesting they can be 
differentially regulated by selective signalling pathways and may therefore serve different 
functions. A few conserved domains have been identified and are depicted in figure 1-9. Of 
particular interest is the interaction domain for the Nab proteins, which is found in Egr-1, Egr-2 
and Egr-3. Nab1 and Nab2 have initially been described as repressors of the transcriptional 
activity of Egr proteins (Russo, Sevetson et al. 1995; Svaren, Sevetson et al. 1996). However, 
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recent data suggest that they can also act as synergistic factors for Egr-2 function at least (Le, 
Nagarajan et al. 2005; Desmazieres, Decker et al. 2008). 
 
 
Figure 1-9.Schematic representation of the four members of the Egr family (Beckmann and Wilce, 
1997).  
DNA binding domain sequences showing the conserved regions of the Egr1-4 family domains. There is 
high homology between Egr-1, Egr-2 and Egr-3. 
  
Egr molecules have mostly been investigated in brain. In brain, Egr family members show, in 
general, a similar regional profile of basal expression. mRNA and proteins are detected in several 
areas of the  brain with different levels of expression (reviewed inBeckmann and Wilce 1997). In 
addition to their basal expression, the expression of Egr family members can be induced in 
different brain areas after a variety of neuronal stimulation paradigms such as the induction of 
LTP or maximal electroconvulsive shocks (MECS) inducing seizure activity, or in behavioural 
circumstances after exposure to novel environments of specific learning experiences. 
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1.3.1 Egr-2 in T cell development 
During thymocyte development two control points govern the number and diversity of mature T 
cells. The first, β-selection, takes place in CD4−CD8−double-negative (DN) thymocytes (Michie 
and Zuniga-Pflucker 2002). The functional rearrangement of the β-chain of the TCR, and its 
association with the invariant pTα chain to form the preTCR, leads to a proliferative burst and 
differentiation into CD4
+
CD8
+
 double-positive (DP) thymocytes. During this transition, the 
TCR-α chain rearranges and associates with the β chain to form the mature αβTCR. The second 
control point, is a selection process that operates to ensure that only those cells bearing TCR with 
appropriate affinity for self-peptide-MHC survive. Most of the immature thymocytes have TCR 
with no or very low affinity for peptide-MHC, and so die by neglect. Thymocytes expressing 
TCR with very high affinity for peptide-MHC are deleted via negative selection. Those 
thymocytes whose TCR have intermediate affinity for peptide-MHC receive survival signals and 
develop into either CD4
+
 single-positive (CD4SP) helper or CD8
+
 single-positive (CD8SP) 
cytotoxic T cells. This process is termed positive selection (Starr, Jameson et al. 2003). Positive 
and negative selection are identified by the activation of distinct signalling pathways downstream 
of the TCR, with Erk1 and 2 essential for positive selection(Fischer, Katayama et al. 2005)and 
p38/Jnk and Erk5 mediating negative selection (reviewed in (Sohn, Thompson et al. 2007). 
Calcineurin signalling is also necessary for positive selection, activating its own downstream 
signalling cascade, and being required to establish the threshold for Erk activation during the 
selection process. 
The early growth response (Egr) transcription factors Egr-1, Egr-2 and Egr-3 are key players 
throughout the development of T lymphocytes. All three are induced upon activation of the pre-
62 
TCR (Carleton, Haks et al. 2002; Lefebvre, Haks et al. 2005) and overexpression can force 
progression through β-selection. Egr-1 and Egr-3 promote survival at β-selection (Carter, 
Lefebvre et al. 2007), and Egr-3 is also required for the post-β-selection proliferative burst to 
occur (Xi, Schwartz et al. 2006). These transcription factors are also induced rapidly following 
ligation of the αβTCR, both during thymocyte selection and in mature T cells responding to 
antigen-MHC, where Egr-1 has a role in upregulation of IL-2 transcription (Collins, Wolfraim et 
al. 2006), and Egr-2 and Egr-3 are required for induction of anergy (Harris, Bishop et al. 2004; 
Safford, Collins et al. 2005) and regulate expression of FasL (Rengarajan, Mittelstadt et al. 
2000). Through its control of self-tolerance, Egr-2 has also been implicated in the development 
of late-onset autoimmune disease (Zhu, Symonds et al. 2008) and is required for the 
development and maturation of NKT cells (Lazarevic, Zullo et al. 2009). 
Upregulation of Egr proteins during positive selection is dependent upon the Ras/MAPK 
pathway. Egr proteins are direct transcriptional targets of ternary complex factor Sap-1, which is 
itself a substrate of Erk and essential for positive selection. In addition, Egr-2 and Egr-3 are 
regulated by calcineurin signalling, likely via NFAT. Both Egr1 and Egr3 have roles in positive 
selection. Egr-1 overexpression enhances positive selection of cells with low affinity TCR. 
Conversely, Egr-1 deficient mice have impaired positive selection (Bettini, Xi et al. 2002); 
although the initial TCR signal is transduced, cells stall at the DP to SP transition, resulting in a 
numerical decrease in CD4 and CD8 SP. Animals deficient for both Egr-1 and Egr-3 have a 
similar but more marked selection phenotype, and CD8 differentiation is significantly impaired 
(Carter, Lefebvre et al. 2007). For both Egr-1 and Egr-3, the principal reason for the alterations 
in SP cell number is a change in the cell‘s susceptibility to apoptosis, at least partly through 
regulation of pro- and anti-apoptotic Bcl2 family members,(Bettini, Xi et al. 2002). 
63 
Egr-2 is similarly important in DP thymocytes. Recently, analysis of mice in which Egr-2 was 
deleted in DN thymocytes has shown that it is not required for negative selection, but that 
positive selection of both CD4 and CD8 lineages is impaired in the absence of Egr-2. This defect 
is at least partially due to increased apoptosis as it is rescued by overexpression of the survival 
factor Bcl-2; however, the mechanism by which Egr-2 might be regulating survival has not been 
established. 
Egr-2 has been found to be important for NKT cell development and positive selection of 
thymocytes in separate studies (Lauritsen, Kurella et al. 2008; Lazarevic, Zullo et al. 2009; 
Lawson, Weston et al. 2010). We have now shown that together with Egr-1 and Egr-3, Egr-2 is 
expressed only in selected stages of T and B cell development and is repressed in ISP 
thymocytes and pro-B cells.  Forced expression of Egr-2 severely impairs the development of DP 
cells in thymus and immature B cells in bone marrow, respectively. In contrast to the defects in 
precursor development in Egr-2 conditonal Transgenic mice (Egr-2 cTg) , the percentage of DP 
cells developed into SP and NKT cells and the percentage of immature B cells into mature B 
cells were increased, suggesting that Egr-2 has a general role in the regulation of progenitors and 
terminal maturation of lymphocytes, but at restricted stages. 
Expression of Egr-1, -2 and -3 molecules can be induced in DN cells upon pre-TCR stimulation. 
The involvement of Egr proteins in β-selection is demonstrated by the fact that overexpression of 
Egr-1 or Egr-3 can overcome the deficiency in β-selection resulting from Rag deficiency and 
drives the development of cells to the ISP stage. However, the most significant and common 
phenotype displayed in transgenic models of Egr-1, -2 and -3 is the reduction of the DP 
population and the increase of ISP cells (Miyazaki 1997), which suggests that Egr molecules are 
important for the development of DN cells following β-selection and lack of Egr-2 expression 
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after β-selection is important for the differentiation of ISP cells to DP cells. Although Egr-1 or 
Egr-2 deficiency does not affect thymocyte development significantly, Egr-3 deficiency results 
in thymic atrophy due to impaired proliferation after β-selection, but the DN to DP transition is 
normal, indicating an important function of Egr molecules in supporting expansion and survival 
of thymocytes after β-selection. The defects in proliferation and survival of thymocytes were 
much more severe in mice lacking both Egr-1 and Egr-3 and observed in both DN and DP 
subsets suggesting a survival function of Egr molecules at early and late stages of thymocyte 
development (Carter, Lefebvre et al. 2007), which is directly supported by our findings that DN 
cells and percentage of DP differentiated to SP and NKT cells are increased in Egr-2 cTg mice. 
A response of transient Egr-3 expression to pre-TCR stimulation has been suggested to be 
important in order to allow later induction of Bcl-XL and RORγt since sustained expression of 
Egr-3 decreases the expression of Bcl-XL and RORγt (Xi, Schwartz et al. 2006): important 
factors for the survival of mature thymocytes during selection. Therefore, overlapping with Egr-1 
and Egr-2, the regulated expression of Egr-3 in response to pre-TCR stimulation is important for 
the maturation of DP cells. The increased maturation of DP cells into SP and NKT cells in Egr-2 
cTg mice indirectly supports the findings that Egr-2 is important for positive selection and the 
development of NKT cells. 
Our results extend the function of Egr-2 to the development of B cells and indicate a similar 
mechanism for the modulation of Egr-2 expression and the function of Egr-2 in regulation of B 
cell progenitors and B cell maturation. The expression of Egr-1 can be induced in pre-, 
immature- and mature-B cells by stimulation with anti-IgM (Dinkel, Warnatz et al. 1998). 
However, the expression of Egr in B cell progenitors is unknown. We have now demonstrated 
that  Egr-1, -2 and -3 are expressed in CLP and pre-pro-B cells and importantly, the expression is 
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repressed in pro-B cells, a similar expression pattern to that seen in DN and ISP thymocytes. In 
addition to the similar expression pattern, the pattern of defects is also similar between B and T 
cell development in Egr-2 cTg mice, as demonstrated by a severe reduction of pro-B cells and 
enhanced terminal B cell maturation, suggesting a common mechanism operated by Egr-2 in 
both lineages. Despite the severe defect of pro-B cells in Egr-2 cTg mice, the development of B 
cells in Egr-2 conditional knock out (cKO) mice is normal. This may be due to the weak activity 
of the CD2 promoter in B cells as shown previously or perhaps due to the redundant function of 
Egr-1 and Egr-3. 
The normal expression of the major molecules involved in cell death and survival and the normal 
apoptosis of thymocytes in the thymus indicate that the abnormalities resulting from sustained 
Egr-2 expression are not due to increased apoptosis. Instead the impaired development of DP 
thymocytes and pro-B cells appears to be due to the blockade of the differentiation of early 
lineage-restricted cells into fully committed pre-B cells or DP thymocytes. One intriguing 
possibility is that the expression of Egr molecules may be inherited from hematopoietic stem 
cells and that Egr molecules may serve to support the early stages of lymphocyte development 
and are then downregulated before final commitment to a specific lineage. 
It has been reported that Egr-1 induces expression of ID3 (Bain, Cravatt et al. 2001). ID3 is one 
of the ID proteins that modulate function of E2A proteins (Yashiro-Ohtani, He et al. 2009). The 
E2A transcription factors are essential for the commitment and differentiation of B and T 
lymphocytes. Deficiency in the E2A pathway results in a defective transition of DN to DP stage 
as seen in Egr-2 cTg mice (Bain, Cravatt et al. 2001). Although E-box ID pathways may be 
regulated by Egr-1, the expression of ID3 is unchanged in Egr-2 expressing DN and ISP cells  
suggesting that Egr-2 does not directly induce ID3 expression. 
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The involvement of Egr-2 in early development of T and B cells is supported by the impaired 
expression of lineage specific transcription factors Notch1 in thymocytes and Pax5 in pro-B cells 
in Egr-2 cTg mice. Activation of the Pax5 and Notch1 pathways is essential for the lineage 
commitment and maturation of B and T lymphocytes, respectively. Pax5 is exclusively expressed 
in the B lymphoid lineage from the committed pro-B cells to the mature B cell stage and controls 
the commitment of lymphoid progenitors to the B cell pathway. Notch signalling is important 
during the early development of thymocytes but the regulation of  Notch expression is not clear 
(Rothenberg 2007). Notch1 is highly expressed at early stages of DN cells and the expression is 
reduced after β-selection and downregulated in DP cells (Yashiro-Ohtani, He et al. 2009). 
Although both Notch1 and Egr molecules are expressed in DN cells, only Notch1 is detected in 
ISP cells. Interestingly, sustained expression of Egr-2 does not affect Notch1 expression in DN 
cells, but reduces it in ISP cells, suggesting that regulation of Notch1 by Egr-2 is conditional 
upon other factors and may depend upon the stage of thymocyte development. Egr-2 has been 
found to play different roles in macrophage differentiation based on its association with PU 
(Laslo, Spooner et al. 2006). PU.1 is expressed in the early stages of T and B cell development; 
whether PU.1 regulates the expression and function of Egr-2 in suppression of the Notch and 
Pax5 signalling pathways at the early stages of DN or pro-B cell development, respectively, 
remains to be investigated. The enhanced maturation of T, NKT and B cells in Egr-2 cTg mice 
could not be explained by the reduced expression of Notch1 in ISP and Pax5 in pro-B cells. The 
completely opposite functions of Egr-2 induced at the early and late stages of lymphocyte 
development suggest that the function of Egr-2 may depend on the function of stage-specific 
transcription factors. The establishment of Egr-1, -2, -3 null and inducible Egr transgenic mice 
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will be essential to define the redundant and specific roles of these three Egr molecules at the 
early and late stages of lymphocyte development and to characterize stage-specific function. 
1.3.2 Egr2 in regulation of immune tolerance 
T cell anergy has been referred to as a tolerant state of T cells and characterized as impaired 
proliferation and IL-2 production following antigen stimulation. T cell anergy has been observed 
both in vitro and in vivo. The induction of anergy has also been observed with antigen 
stimulation in the absence of costimulatory signals (Anderson, Manzo et al. 2006). In addition to 
a nearly complete block in IL‐2 production and proliferation, anergic T cells show reduced 
secretion of other cytokines such as interferon‐γ (IFN‐γ) and IL‐3. The anergic state can be 
long‐lived and stable for weeks, but in these model systems it is reversible by the addition of 
exogenous cytokines such as IL‐2 or IL‐15 (Beverly et al. 1992; Essery et al. 1988). This 
reversibility has motivated further investigation of anergy in the settings of cancer and chronic 
infection, in which restoration of correct T cell function is one of the main therapeutic goals. 
Thus, the understanding of tolerant mechanisms is important for immune intervention.  
On the basis of the in vitro anergy model systems, the signal transduction events that drive the 
induction of anergy rather than full T‐cell activation seem to involve the disproportionate 
over‐activation of calcium/nuclear factor of activated T cells (NFAT) signalling compared with 
other biochemical signalling intermediates, such as the Ras/mitogen‐activated protein (MAP) 
kinase pathway. The addition of calcium ionophores alone—such as ionomycin—is sufficient to 
induce anergy of T cells. Conversely, induction of anergy with CD3 monoclonal antibodies can 
be prevented by cyclosporin A, which blocks NFAT‐dependent signalling.  See figure 1-10  
(Chai & Lechler, 1997). Together, these results suggest a model in which excessive 
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calcium/NFAT signalling results in transcriptional upregulation of negative regulatoryproteins 
that inhibit correct TCR/CD28 signalling. 
 
Figure 1-10.Signals leading to the induction of anergy (Chai and Lechler, 1997). 
Excessive calcium/NFAT signalling leads to upregulated expression of negative regulatory 
factors that inhibit aspects of TCR/CD28‐dependent signalling) 
 
1.3.3 Potential role for Egr family transcription factors in the induction of T 
cell tolerance 
Egr-2 and Egr-3 have been found to be induced in tolerant or anergic T cells by antigen receptor 
stimulation (Anderson, Manzo et al. 2006). The induction has been found to be dependent on 
NFAT activation (Hsiao, Liu et al. 2009). Overexpression of Egr-2 and Egr-3 reduced IL‐2 
production in T cells and has been shown to upregulate Casitas B‐cell lymphoma‐b (Cbl‐b), one 
of the E3 ligase (Zheng, Zha et al. 2008). Conversely, Egr3‐deficient T cells were relatively 
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resistant to anergy induction in an in vivo peptide‐induced anergy model (Safford et al. 2005).  
As discussed below, Cbl‐b has also been implicated as a contributor to the anergic state and is 
upregulated on Egr2/3 overexpressed T cells, perhaps suggesting that Egr proteins are regulating 
the transcription of several anergy‐associated genes. 
Consistent with a potential role for E3 ubiquitin ligases in the anergy phenomenon, T cells 
overexpressing Egr-2 or Egr-3 have a high basal level of Cbl‐b. Conversely, no increase in Cbl‐b 
expression was seen on anergy induction in Egr-3‐deficient T cells (Safford et al. 2005). 
However, whether E3 ubiquitin ligases are involved in the induction compared with the 
maintenance of T‐cell anergy is not yet clear, and how they relate to altered Ras activation in the 
anergic state has not been established.  
The molecular alterations in anergic T cells have become clearer as a result of recently published 
experiments. A current working model suggests that excessive calcium/NFAT‐based signalling 
leads to upregulated expression of Egr-2 and/or Egr-3, which in turn drives the expression of 
several negative regulators of TCR‐based signalling. Upregulated E3 ubiquitin ligases might 
contribute to disrupted signalling through ubiquitination and either degradation or altered 
subcellular localization of other signalling intermediates. Further in‐depth study of the regulation 
of T‐cell anergy should lead to the development of pharmacological approaches either to 
promote the anergic state in settings of autoimmunity and transplantation, or to restore T‐cell 
function in the settings of cancer and chronic infection. 
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1.3.4 Egr-2 regulates T cell homeostasis and controls the development of 
autoimmune diseases 
Recently, we and others have found that Egr-2 is induced in tolerant T cells in response to 
antigen stimulation in vivo or TCR ligation in vitro (Harris, Bishop et al. 2004; Safford, Collins 
et al. 2005; Anderson, Manzo et al. 2006). Together with Egr-1 and Egr-3, Egr-2 is expressed in 
thymocytes and in mature T cells upon TCR stimulation.  RNAi mediated knockdown of Egr-2 
in an established T cell line rendered the cells less susceptible to anergy induction (Harris, 
Bishop et al. 2004), while overexpression of Egr-2 reduced T cell activation in vitro indicating 
that Egr-2 regulates genes involved in the suppression of T cell activation.  However, the 
function of Egr-2 in T cells in vivo under homeostasis condition has not been studied as Egr-2 
knockout mice die prenatally due to defects in hindbrain development (Topilko, Schneider-
Maunoury et al. 1994). 
To assess the function of Egr-2 in T cells in vivo, we have established Egr-2 conditional 
knockouts (Egr-2 cKO), in which the Egr-2 gene was deleted specifically in CD2
+
 lymphocytes. 
The Egr-2-deficient T cells did not show altered primary activation, but were hyperproliferative 
in response to prolonged stimulation and exhibited a Th1 and Th17 bias leading to the 
development of a lupus-like syndrome in older mice. Defective expression of p21cip1 was 
detected in CD44
high
 T cells from Egr-2 cKO mice and Egr-2 was found to interact directly with 
the promoter of p21cip1 in vivo. In addition, IFN-γ and IL-17 were highly induced in Egr-2 
deficient T cells and accumulation of IFN-γ and IL-17-producing cells was associated with 
massive infiltration of  T cells in multiple organs. Our results demonstrate that Egr-2 is important 
for controlling the self-tolerance of T cells and preventing autoimmunity through activation of 
negative regulators of cell proliferation and by controlling proinflammatory cytokine expression. 
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We and others have previously found that Egr-2 is induced in tolerant T cells following TCR 
stimulation (Harris, Bishop et al. 2004; Anderson, Manzo et al. 2006). We have now found that 
Egr-2 is normally expressed in CD44
high 
T cells and that Egr-2 deficiency results in a massive 
accumulation of these cells. CD44
high
 is a marker for effector or effector memory T cells (Surh, 
Boyman et al. 2006). The CD44
high
 T cells in wild-type mice raised in a clean environment are 
presumably generated in response to commensal antigens, gut-flora or self-antigen. In contrast to 
the resting CD44
low
 naive T cells, CD44
high
 cells undergo slow and intermittent proliferation in 
response to homeostatic stimuli such as self-antigen and cytokines (Curtsinger, Lins et al. 1998), 
and also it has been found that CD44
high
 memory T cells are intrinsically more sensitive than 
CD44
low
 naive cells to stimulation through the TCR/CD8 complex.The expression of Egr-2 in 
CD44
high
 cells may be induced from homeostatic responses to serve as a feedback mechanism to 
control the proliferation and activation of CD44
high
 T cells. The development of systemic 
autoimmune responses in Egr-2 cKO mice demonstrates the importance of such controls.  
Several findings in predisposed mice appear to support the notion that primary or secondary 
homeostatic lymphocyte perturbations, such as in MRL-Fas
lpr
, and p21cip1 KO mice of 
C57BL/6 background, contribute the pathogenesis of spontaneous lupus (Balomenos, Martin-
Caballero et al. 2000; Lawson, Baccala et al. 2004). These findings suggest that uncontrolled T 
cell proliferation can lead to T cell expansion and generation of effector cells to self-antigens 
resulting in the development of lupus-like systemic autoimmune diseases. Our results indicate 
that Egr-2 is an intrinsic regulator that not only controls proliferation, but also inflammation of 
effector T cells and inhibits the development of lupus-like autoimmune diseases. The 
accumulation of IFN-γ and IL-17 producing CD4+ T cells in Egr-2 cKO mice suggests the 
possibility that the activated CD4
+
 T cells are effector inflammatory T cells primed by self-
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antigen and that the loss of tolerance in Egr-2 cKO mice leads to the expansion of these cells and 
autoimmune responses.  
We found that the cell cycle inhibitor p21cip1 is a direct target gene of Egr-2. Egr-2 deficiency 
results in defective expression of p21cip1 in CD44
high
 T cells. Most of the reports from p21cip1
-/-
 
mice have shown enhanced T cell activation, proliferation and autoimmune manifestations which 
are largely consistent with Egr-2 cKO mice. However, a study in the BXSB atypical lupus model 
showed that p21cip1 deletion increased apoptosis of activated T cells and decreased disease 
incidence in male mice suggesting that p21cip1 regulates proliferative responses by blocking 
apoptosis. However, the increased apoptosis in response to TCR stimulation suggests a 
differential effect of p21cip1 in the activation and proliferative responses of T cells. In a recent 
study in C57BL/6 mice, p21cip1 deletion only enhanced T cell proliferation at a late stage of 
stimulation consistent with our findings in Egr-2 cKO mice of C57BL/6 background. Taken 
together, these studies indicate that p21cip1 is involved in the regulation of effector T cell 
proliferation, but plays only a part of the tolerance program and its function in lupus 
development is dependent on the genetic pre-disposition. Indeed, in addition to the altered 
expression of p21cip1, enhanced differentiation of Th1 and Th17 cells in Egr-2 cKO mice was 
found. Although no studies have shown yet how Egr-2 regulates the expression of 
proinflammatory cytokines, the accumulation of Th1 and Th17 cells can directly result in 
infiltration of T cells into multiple organs and inflammatory autoimmune diseases (Porter and 
Clipstone 2002). These results have not been reported in p21cip1-deficient mice (Balomenos, 
Martin-Caballero et al. 2000). 
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The increased expression of IFN-γ and IL-17 in Egr-2 deficient T cells following TCR ligation 
suggests that Egr-2 may be involved in the control of inflammatory cytokines in effector T cells. 
Such control may not only be important to prevent inflammatory reactions of autoreactive T cells 
but also for the reduction of immunopathology during a productive immune response. Although 
both Th1 and Th17 are observed in most autoimmune models, the mechanisms mediating Th1 
and Th17 differentiation in vitro are distinct (Porter and Clipstone 2002), while the in vivo 
mechanisms are still unknown. NFAT has been found to induce IFN-γ expression and activate 
the IL-17 promoter (Liu, Lin et al. 2004). Egr-2 is one of the NFAT target genes in T cells. 
Therefore, the expression of Egr-2 could act as negative feedback loop to control IFN-γ and IL-
17 expression in response to TCR stimulation. Although we did not find altered activation of 
NFAT in Egr-2 deficient T cells from aged mice (data not shown), the possibility that Egr-2 
physically interacts with NFAT and inhibits its activity has yet to be analysed. The reduced 
production of Th2 cytokines could either result from enhanced Th1 and Th17 differentiation or 
direct regulation by Egr-2; this remains for future investigation.  
Both Egr-2 and Egr-3 are expressed in double negative thymocytes (DN) and defective 
expression of Egr-3 leads to the accumulation of DN and reduction of DP thymocytes in the 
thymus (Carter, Lefebvre et al. 2007), indicating that Egr-3 is involved in thymocyte 
development before thymocyte selection. However, we did not find a similar phenotype in the 
thymus of Egr-2 cKO mice suggesting that either Egr-2 function at this stage is redundant or that 
Cre mediated deletion was incomplete at this stage. T cell lines over-expressing Egr-2 or Egr-3 
show an upregulation of Cbl-b and reduced production of IL-2 (Harris, Bishop et al. 2004; 
Safford, Collins et al. 2005). This finding led to the hypothesis that the mechanism for Egr-2 in 
maintaining T cell tolerance would be the downregulation of TCR signalling. However, we could 
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not detect differences between Egr-2-deficient and wild-type naive T cells in the major TCR 
signalling pathways, such as AP1, NFκB, NFAT and MAP kinase following TCR stimulation in 
vitro (data not shown). In addition, we did not observe hyperproliferation of naive Egr-2 cKO T 
cells in response to primary TCR stimulation. This normal response to TCR engagement could 
be due to functional compensation by Egr-3 (Safford, Collins et al. 2005). Nevertheless, the 
continuously proliferating T cell lines and pre-activated primary T cells used in these studies 
share some features of the hyperactive CD44
high
 T cells in Egr-2 cKO mice. Therefore, the 
negative regulation of T cell activation in these reports is consistent with the hyperproliferation 
and activation of Egr-2-deficient T cells in vivo.  
Egr-2 has been found to induce FasL expression in T cells (Mittelstadt and Ashwell 1999). 
Deficiency in Fas expression in MRL/lpr mice results in severe lupus-like disease due to the 
resistance of T cells to apoptosis (Lawson, Baccala et al. 2004). However, Egr-2 deficiency did 
not alter expression of FasL in T cells or apoptosis in either young or old mice and CD3
+
CD4
-
CD8
- 
T cells were not detected in spleen of old Egr-2 cKO mice , suggesting distinct mechanisms 
for lupus-like disease in Egr-2 cKO and MRL/lpr mice. Recently, reduced expression of Egr-2 
and Egr-3 has been found in T cells from BALB/c mice after induction of lupus like disease by 
an anti-DNA antibody, and the decreased expression was associated with increased IFN-γ 
secretion(Kang, Liu et al. 2007), suggesting that Egr molecules are involved in the maintenance 
of self-tolerance.  
Although anti-nuclear antibodies are hallmarks of systemic lupus, the mechanisms responsible 
for the breakdown of self-tolerance are still unknown. One of the characteristics of the 
autoimmune disorder in lupus patients is Th1 mediated inflammation with a high level of IFN-γ 
production and increased serum IgG2a antibody, both of which we have observed in aged Egr-2 
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cKO mice (Zhu, Symonds et al. 2008). In addition, a massive increase of IL-17 production in 
activated T cells and an increased percentage of Th17 cells in Egr-2 cKO mice were observed. 
Th17 plays an important role in the development of lupus-like disease (Pernis 2009). These 
results suggest that autoimmune disorders can result from a loss of control of effector T cell 
expansion and inflammatory activation and that this control is mediated by genes regulated by 
Egr-2.  
Peripheral T cells are tolerant to self antigens, which is achieved by limiting the expansion and 
activation of self-reactive T cells (Schwartz 2003). In addition to the function of regulatory T 
cells (Germain 2008), a number of intrinsic mechanisms have been discovered which either 
induce T cell anergy or limit T cell expansion (Lin and Mak 2007), such as the GRAIL E3 ligase 
which is induced in anergic T cells and inhibits IL-2 expression by targeting TCR signalling 
molecules. In addition, control of T cell growth and regulation of apoptosis are also important 
mechanisms to maintain self-tolerance. Egr-2 has been found to regulate expression of an E3 
ligase (Safford, Collins et al. 2005) and we have shown that Egr-2 directly activates p21cip1 
expression in CD44
high
 T cells and is involved in the regulation of T cell homeostasis leading to 
the control of autoimmunity (Zhu, Symonds et al. 2008). 
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AIMS 
Although Egr-2 plays an important role in the regulation of immune homeostasis, it function in 
regulation of effector T cells, especially in the differentiation of Th cells, is still unknown. This 
study aims to investigate the function of Egr2 in the control of Th17 differentiation and Th17 
associated autoimmune diseases. 
  
78 
 
This study is supported by Arthritis Research UK 
 
 
CHAPTER 2 
MATERIALS AND METHODS  
79 
 
2 MATERIALS AND METHODS 
2.0 Experimental Murine Models 
For a better understanding of the Egr-2 gene intrinsically, we used mice as experimental models 
because they are small, prolific and we can manipulate their genetics in ways not possible with 
humans. The mouse strain we used were the C57BL/6 mice as a genetic background due to the 
availability of congenic strains, easy breeding, and robustness. All mice used in this study were 
maintained at Brunel University‘s Biological Service Unit and used according to established 
institutional guidelines under the authority of a UK Home Office project licence (Guidance on 
the Operation of Animals, Scientific Procedures Act 1986). 
2.0.1 EGR-2 conditional knockout mice 
Previous studies to look at the functions of physiological levels of Egr-2 in T cells in vivo have 
been proven difficult to study as Egr-2 knockout (Egr2
-/-
) mice die postnatally due to defects in 
hindbrain development (Schneider-Maunoury, Topilko et al. 1993). Our group overcame this by 
establishing Egr-2 conditional knockouts (Egr-2 cKO) in which the Egr-2 gene was deleted 
specifically in CD2
+
 lymphocytes using the cre loxP system. 
We used the cre-loxP system as a transgenic tool to artificially control the expression of Egr-2 by 
deleting Egr-2 in CD2
+
 lymphocytes. The human CD2 (hCD2) promoter, which is lymphocyte 
specific, drives expression of the Cre-recombinase. Therefore, the Egr-2 gene is selectively 
deleted in CD2 positive cells in Egr-2 cKO mice. This allows for lineage studies of lymphocytes 
80 
 
and allows us to further investigate the contribution of specific effector T cells to immune 
responses and immunological disorders (see Figure 2-1). 
 
Figure 2-1.Cre-Loxp mouse model 
Diagram showing the Egr-2 gene being deleted out and regulated by CD2 promoter of 
conditional EGR-2 KO mice. 
 
The Egr-2 cKO model was generated by crossing of hCD2-Cre transgenic mice (a gift from Dr 
D. Kioussis, National Institute for Medical Research, London.) and Egr-2-floxed mice (Egr-2 
loxP/loxP
) a gift from Dr P. Charnay, Institut national de la santé et de la recherche médicale, Paris 
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France. (Taillebourg et al. 2002; de Boer et al. 2003). In these mice, the Egr-2 expression is 
normal in the tissues in which the Cre is not expressed. 
2.0.2 Genotyping 
To identify the EGR-2 cKO mice used in this study, the mice were genotyped. Genomic DNA 
was extracted from mice tails using the REDExtract-N-Amp Tissue PCR Kit (Sigma) by 
manufacturer‘s instructions; this work was done at Brunel University by Emma Ghiraffe and 
Punam Bhullar. The mice tails were cut between 12-14 days of age as the tail tissue is soft and 
yield of DNA is at its highest.  
The genomic DNA was then amplified up by Polymerase Chain Reaction (PCR).This technique 
allowed selective amplification of the Cre and LoxP locus using sequence specific primers to Cre 
and Lox-P transgene (see Figure 2-2). The advantage of this method is that it allows for 
exponential amplification of the variant DNA sequences using Taq (Thermus aquaticus) a 
thermostable DNA polymerase enzyme that is stable at very high temperatures required during 
PCR and is not denatured at the same temperature required for DNA denaturing and so allowing 
for many rounds of extension without adding more enzyme for each cycle. The Taq enzyme 
extends the primers by incorporating dNTPs complementary to the pre-existing strand and so 
producing a copy of the DNA. 
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Table 2-1. Primer sequences and PRC cycle run used for genotyping 
Gene of interest Primer sequence PCR cycle 
 
hCD2 EGR-2 KO 
LoxP 
 
Sense5‘-GGG AGC GAA GCT ACT CGG ATA CGG-3‘ 
Antisense5‘- GTG TCG CGC GTC AGC ATG CGT- 3‘ 
 
 
95˚C for 5mins 
94˚C for 40sec 
65˚C for 40sec 30 cycles 
72˚C for 40sec 
72˚C for 5mins 
 
 
hCD2 EGR-2 KO 
Cre 
 
Sense 5‘-CCA ACA ACT ACC TGT TCT GCC G-3‘ 
Anti sense 5‘-TCA TCC TTG GCA CCA TAG ATC AGG-3‘ 
 
95˚C for 5min 
94˚C for 40sec 
56˚C for 40sec 30 cycles 
72˚C for 40sec 
72˚C for 5min 
 
 
PCR was performed as per the manufacturer‘s protocol with a final primer concentration of 
0.5μM. The DNA amplicons were then detected by gel electrophoresis using a 2% agarose gel 
(Figure 2-2). Mice positive for cre where either homozygote as in samples 1 and 5 that were 
present for LoxP and WT allel or heterozygote, those were positive for the LoxP allel. To 
confirm that Egr-2 
loxP/loxP
 hCD2-Cre mice have Egr-2 deleted in the T cells, splenic CD4 T cells 
were isolated and stimulated with anti-CD3 and anti-CD28, Egr-2 mRNA was examined by Real 
Time PCR, while protein was analysed by Western Blot (Figure 2-2 B and C).  
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Figure 2-2.Genetic characterization of EGR-2 cKO mice 
hCD-2-Cre mice were crossed with EGR-2 loxP/loxP mice to generate EGR-2
loxP/loxP 
hCD2-Cre 
(EGR-2 cKO) mice.(A) Extraction of genomic DNA from tail samples of EGR-2 cKO mice and 
identified by PCR for Cre and LoxP. The white box highlights EGR-2 cKO heterozygous mice 
which were not used. Splenic CD4
+
 cells were isolated from EGR-2 cKO mice  and C57/Blk6 WT 
mice and stimulated with anti-CD3 and anti-CD28 for 16 hours. mRNA expression of EGR-2 
B
Cre positive band 150 bp
Egr-2 loxP/loxP hCD2-cre mice 
(samples 1-7)
LoxP allel 210bp
WT allel 195 
bp
A
WT     cKO WT       cKO
EGR-2
Bactin
c
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was quantified by Real Time QPCR (B) and western blot (C) Bactin was used as a loading 
control. 
 
2.1 T cell isolation 
To study the naive CD4 T cells of Egr-2 cKO mice and to compare them with WT mice we used 
the spleens and lymph nodes of each mouse (dissection preformed at Brunel University).  We 
used young mice between 6 to 8 weeks to avoid bias that could  be created in an Egr-2 deficient 
environment by the onset of inflammatory disease. 
Total mice spleens and lymph nodes were first mashed to break up the tissue up using a cell 
strainer and syringe end, and then washed with Phosphate Buffer Saline (PBS). The cell 
suspension is centrifuged at 12,500 rpm for five minutes at room temperature (RT) and 
supernatant taken off. The erythrocytes are lysed from the cell pellet using 0.9% ammonium 
chloride lysis buffer at 37ºC for five minutes. The erythrocytes lysed due to the hypotonic 
solution in the lysis buffer. Next diluting with PBS stops the lysis and a further centrifugation at 
12,500 rpm for five minutes at RT is needed. 
To study the function of Egr-2 in lymphocytes we isolated naive CD4
+
T cells and further 
purified them by CD62L. The cell adhesion molecule CD62L (L-selectin) is highly expressed on 
naive T cells and down-regulated upon activation. This makes sure that we start with a true naive 
CD4
+
 T cell population and eradicates the possibility of already differentiated cells. We 
preformed Magnetic Activated Cell Sorting (MACS) using CD4
+
 CD62L
+ 
T cell isolation beads 
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(CD4
+
 CD62L
+
 T Cell Isolation Kit II mouse Miltenyl Biotec) according to manufacturer‘s 
instructions. Brief description: Total mice splenocytes of both WT and EGR-2 cKO mice were 
extracted as previously described in to a single cell suspension of 10
8 
total cells respectively. 
Cells and solution buffers are kept cool to prevent capping of antibodies on the cell surface and 
non-specific cell labeling. 
Non CD4
+
 T cells were indirectly magnetically labeled with a cocktail of biotin-conjugated 
monoclonal anti-mouse antibodies against CD8a, CD45R, CD11b, CD25, TCRγ/δ and Ter-119 
and incubated for 10 minutes at 4ºC. Anti biotin microbeads (isotype mouse IgG1) are added 
with buffer (PBS, 0.5% BSA and 2mM EDTA) and cells are further incubated for 15 minutes at 
4ºC. Following centrifugation at 300xg for 10 minutes at 4ºC and resuspension in 500ul buffer. 
The cell suspension runs through a LS column, which magnetically attaches  to a MACS 
separator; the unlabelled cells pass through and are collected. The total effluent contain 
unlabelled pre enriched CD4
+ 
T cell fraction. Next step cells are centrifuged 300 x g for 10 
minutes and resuspended in 800ul of buffer. They are directly labelled with 200ul CD62L (L-
selectin) Microbeads and incubated at 4ºC for 15minutes. Cells are then washed with 10 ml of 
buffer and centrifuged at 300 x g for 10 minutes. Following resuspension in 500ul of buffer the 
cells  run through an MS column, magnetically attached to MACS separator. Cells are next 
isolated by positive selection from the pre-enriched CD4
+
T cell fraction. The magnetically 
labelled CD4
+
CD62L
+
 T cells are retained on the MS column and eluted after removal of the 
column from the magnetic field (Figure 2-3). The isolated cells were 95% of 
CD4
+
CD62L
+
CD44lowCD25-. 
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Figure 2-3. The principle of MACS Separation 
 
2.2   Effector T helper differentiation studies 
For differentiation studies of naive CD4
+
 T cells to effector T cells, we had a starting population 
of naive 95% of CD4
+
CD62L
+
CD44lowCD25- for cells derived from both WT and EGR-2 cKO 
respectively. Co-stimulatory cytokines anti-CD3 5ug/ml and anti-CD28 2ug/ml were used to coat 
48 well Nunc tissue culture treated plates and left overnight at 4ºC (we started with six well 
plates but found the cells grew better in a smaller surface area). Cells seeded at 0.25 x10
6 
cells 
per well and cultured in 100ul Iscove‘s Modified Dulbecco‘s Media (IMDM) supplemented 
with300mg/ L-glutamine, 100U/ml penicillin, 100ug/ml streptomycin, 5x10
5
M β-
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mercaptoethanol and 5% heat inactivated Fetal Calf Serum. Next step another 100ul of medium 
was added to all the wells together with various Th cytokine stimulation cocktails (see  
Table 2-2). Anti IL-4 is added in Th1 conditions to stop differentiation of Th2, and anti IFN-γ in 
Th2 conditions to stop differentiation into Th1. Both cytokines anti IL-4 and anti IFN-γ is used 
to stop differentiation of Th1 and Th2 in Th17 conditions. To note: we first started using mouse 
IL-6 but found Human IL-6 to be more reactive. Cells are left for four days in culture at 37°C to 
proliferate and differentiate. 
 
Table 2-2. Effector Th cytokine cocktail 
 
Effector T cell 
 
Cytokine cocktail added to 100μl of IMDM 
Th0 No Cytokines added 
 
Th1 10ng/ml IL12 
10ng/ml anti IL4 
Th2 10ng/ml IL4 
10ng/ml anti IFNg 
 
Th17 
50ng/ml Human IL6 
1ng/ml TGFB 
10ng/ml IL1b 
10ng/ml anti IFNg 
10ng/ml anti IL4 
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2.3 Brdu Assay  
To look into the proliferation of CD4
+
 T cells in vivo, we used BrdU to detect its incorporation 
in to the cells. BrdU (Bromodeoxyuridine) is a thymidine analogue that is readily taken up by 
proliferating cells and incorporated into newly synthesized DNA by cells progressing through 
DNA synthesis (S) phase and cell cycle. Using an anti-BrdU antibody, S phase cells can then be 
detected and analysed by flow cytometer.  BrdU (from Sigma) at 10µM was added to the cells 
for 4 hours. The cells are then harvested into microtubes and centrifuged twice .  PE-Anxin V 
antibody is used at 2ul and incubated at 4 ̊C for 30 min. Cells are then washed once with PBS 
and 200ul of fixation buffer (BD) is added and left on ice for 10 minutes . Cells are then 
centrifuged and supernatant removed. PBS is added at 1ml and washed twice. Cells are then 
permeambilised by adding 500ul of 0.5% Triton X-100 in PBS and incubated for 15 mines at 
room temperature followed by two wash steps with PBS. Resusupension of cells by adding 500ul 
of 1x DNase I buffer and 50ul DNase I solution. Cells are incubated at 37 C for 45 mins. This is 
followed by a further three wash steps with PBS.  Anti – Brdu at 2ul is added and incubated for 
20mins at room temperature. Cells are washed and 50ul of IL2 and incubated in the dark for 20 
minutes at room temperature. Cells washed once and resuspended in 50ul RNaseA (100ug/ml) 
and 200ul PI (50ug/ml) and incubated for 10 minutes. Cells were then analysed on flow 
cytometer. 
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2.4 [3H]TdR proliferation Assay to Methods 
To analyse proliferation of T cells tritiated thymidine ([3H]TdR) incorporation was measured by 
help of  Dr B. Zhu. This technique takes advantage of the fact that as cells proliferate they 
replicate their DNA. This technique uses the nucleotide thymidine (TdR) that is labelled with a 
radioactive isotope of hydrogen called tritium (3H). As the cells proliferate they take up this 
[3H]TdR and incorporate it into their DNA. Thustritium incorporation is proportional to DNA 
synthesis and hence to proliferation. To measure [3H]TdR incorporation, purified CD4+ T cells 
(5×104 cells/200μl) in 96-well plates were stimulated in triplicate for 72 hours. 1μCi of [3H]TdR 
was added to each well for the last 8 hours of culture, then the DNA was harvested onto glass 
fibre filters and unincorporated [3H]TdR was washed away. Tritium incorporation was measured 
by 54 scintillation counting; tritium emits radiation which excites scintillation fluid causing it to 
emit light which can then be detected. 
 
2.5 Extraction of RNA 
Total RNA is extracted using the Trizol reagent (Invitrogen). This method separates nucleic 
acids from other cellular components. The protocol uses acidic conditions, which separates the 
RNA from the DNA and proteins following chloroform extraction. The solution also contains 
Guanidinium thiocyanate; a strong denaturing agent which denatures any proteins, such as 
RNAse, present in the sample (Chomczynski and Sacchi 2006). Cultured CD4
+
 cells (under 
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various stimulating treatments) from WT and EGR-2 cKO mice were pelleted and then lysed in 
1ml of Trizol per 10
7
 cells and then incubated at room temperature for 10 minutes. 200µl of 
Chloroform is then added, the sample mixed vigorously, incubated at room temperature for five 
minutes and then centrifuged. After centrifugation the sample separated into a red organic phase 
and a clear aqueous phase separated by a white interphase. The RNA separated into the aqueous 
phase while proteins and DNA remained in the interphase. The aqueous phase is transferred to a 
new tube and the RNA was precipitated by the addition of isopropanol. Nucleic acids are not 
soluble in alcohol and so the RNA precipitates out of solution. In addition, in situations where 
the initial cell number was low, glycogen is added; glycogen is also not soluble in alcohol and 
co-precipitates with the RNA, aiding visualization of the RNA pellet. The RNA pellet is then 
incubated at −20°C for one hour and spun down. The RNA pellet is next washed with 70% 
ethanol and then resuspended in RNAse-free water. 
2.5.1 RNA purity and integrity 
High quality, intact RNA is essential for full length, high quality cDNA synthesis. To quantify 
the amount of RNA present, a nanodrop spectrophotometer is used to measure the absorbance at 
260nm. 
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Figure 2-3.Gel and graphs showing integrity of RNA of 28s and 18s and rRNA bands 
All samples had clear bands and RIN number of above 8.00 
92 
 
2.6 RNA to cDNA 
RNA was converted to first strand cDNA (copy DNA) using a reverse transcriptase enzyme, 
superscript III from Invitrogen. The reverse transcriptase enzyme catalyses the formation of a 
complementary cDNA strand using the RNA strand as a template. Oligo-dT nucleotides will then 
anneal to the poly-A tails of mRNA and act as primers for reverse transcriptase. Using nuclease 
free thin walled PCR tubes 2µg of total RNA and 0.5µg of oligo-dT was added in to the tube 
along with sterile distilled water to give final volume of 13ul. dNTP‘s were also added 10µM of 
each dATP, dTTP, dCTP and dGTP. The samples were then heated to 65°C for five minutes to 
denature any secondary structures present in the RNA, helping the binding of the oligo-dT 
primers. 
The samples were then placed on ice for 1 minute and 1µl of RNAse inhibitor, 1µl DTT 
(Dithiothreitol), 4µl 5x Reaction Buffer and 1µl Superscript III (200 units/µl) was added to each 
reaction (all from Invitrogen). The reactions were then heated to 37°C for 1 hour and then 70°C 
for 15 mins to inactivate the Superscript enzyme. The cDNA was then ready to be used as a 
template for Real Time Quantitative PCR. 
2.7 Real Time Quantitative PCR 
Real Time Quantitative Polymerase Chain Reaction (Real Time QPCR) uses the same principle 
as normal PCR which amplifies up large amounts of a target DNA sequence using specific 
primers and enzyme conditions. Real Time QPCR exceeds the limitation of PCR as the amplified 
DNA detects the reaction progresses in ‗real time‘. This is a new approach compared to standard 
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PCR, where the product of the reaction  detects at its end-point on an agarose gel. The advantage 
of Real Time QPCR is that it allows quantification between samples against a reference gene. 
The reference genes are also known as housekeeping genes, they are constitutive genes that are 
required for the maintenance of basic cellular function, and isexpressed in all cells of an 
organism under normal and patho-physiological conditions. We tested a number of housekeeping 
genes on our samples for both mouse and human genes and we found the best housekeeping 
genes where there was no change in expression, and expression was high in mouse to be Beta 
actin (β-actin) and in humans to be B2M.  
The method for the detection that we used was SYBR® Green I, a nonspecific asymmetrical 
cyanine dye (Zipper, Brunner et al. 2004) that intercalates with all double-stranded DNA (see 
Figure 2-4). The resulting DNA-dye-complex absorbs blue light (λmax = 497 nm) and emits 
green light (λmax = 520 nm). Detection is monitored by measuring the increase in fluorescence 
throughout the cycle. Real time PCR was performed with the QuantiTect SYBR Green PCR kit 
(Quiagen) as per the manufacturer‘s instructions using 1µl of relevant cDNA and a final 
concentration of 0.2µM of relevant sense and antisense primers (see Figure 2-5 and Table 2-3) in 
1x SYBR Green master mix containing HotStarTaq DNA Polymerase (high specificity and 
sensitivity) and ROX dye which allows fluorescence normalization. Real Time QPCR performs a 
relative quantification based on the relative expression. The data was analysed using the Rotor-
Gene Software. All samples were run in duplicate, and relative mRNA expression levels were 
obtained by normalizing against the level of β-actin for mice samples or B2M for human samples 
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from the same respective samples under the same program using
∆∆
CT method (Livak and 
Schmittgen 2001): relative expression=2^(CT(β-actin)– CT(target gene))*10,000. 
 
Figure 2-4.Diagram showing the binding of SYBR Green dye in Real Time QPCR 
Adapted from Applied Biosystems (www.appliedbiosystems.com) 
95 
 
 
Real time PCR was performed on a Rotor-Gene system (Corbett Robotics) using the program 
listed below: 
1. 95°C for 10min 
2. 95°C for 20s 
3. 58°C (varies depending on Tm) for 30s 45 cycles 
4. 72°C for 20s 
Step 1: the initial activation step where HotStarTaq DNA Polymerase is activated by this heating 
step.  
Step 2: in addition to denaturing the DNA, it also denatures the antibody that is bound to the 
DNA polymerase.  
Step 3: Annealing, the temperature is always set 5-8C below the melting temperature of primers.  
Step 4: Extensioncatalyse DNA synthesis during the elongation phase. During each elongation 
phase fluorescence data was collected. This cycle is repeated 45 times. 
Figure 2-5. PCR cycle run 1 
 
2.7.1 Primer design 
To find the genes of interest to amplify up, we first looked up their nucleotide sequence using the 
National Center for Biotechnology Information website (www.ncbi.nlm.nih.gov/) nucleotide 
database.  
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The sequence runs through the Primer-Blast software (www.ncbi.nlm.nih.gov/tools/primer-blast) 
where primers are picked to the specific PCR template, under certain critical criteria for optimal 
amplification with high yield. The primers were designed to be 20-25 nucleotides in length, long 
enough for adequate specificity and short enough for primers to bind easily to the template at the 
annealing temperature. They were also designed to have a 40-60% GC content to ensure stable 
binding of primer/template as G-C bonds contribute more to the stability (increased melting 
temperatures) of primer/template binding than do A-T bonds. The GC clamp was also set so 
there would be G or C base at the 3′ end of primers. This helps to promote correct binding at the 
3′ end due to the stronger hydrogen bonding of G and C bases. However strings of G and C,  
more than 3 repeats in the first five bases of  the 3‘ end were avoided. As they form internal, 
non-Watson-Crick base pairs that disrupt stable primer binding and form primer dimer (self 
dimers that are due to intermolecular interactions of the same primer and cross dimer that are 
intermolecular interactions between sense and antisense primers). We selected primers with a 
random base distribution and contained fewer than four complementary bases especially at the 3′ 
end as this can lead to the formation of product artifacts arising from amplified primer-dimers 
and primer-oligomers to form homo-dimers or hetero-dimers. 
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Table 2-3. Forward and Reverse mouse primers used for Real Time quantitative PCR 
Primer Sense Antisense 
Annealing 
Temperature 
Egr-2 5‘-CTTCAGCCGAAGTGACCACC-3' 5‘-GCTCTTCCGTTCCTTCTGCC-3‘  58°C 
IL-2 5‘-GCATGTTCTGGATTTGACTC-3‘ 5‘-CAGTTGCTGACTCATCATCG-3‘  58°C  
IL-17A 5‘-AGCGTGTCCAAACACTGAGG-3‘ 5‘-CTATCAGGGTCTTCATTGCG-3‘ 59C 
IL-17F 5‘-AACCAGGGCATTTCTGTCCC-3‘ 5‘-TTTCTTGCTGAATGGCGACG-3‘ 59C 
IL-1a 5‘-ATGTATGCCTACTCGTCGGG-3‘ 5‘-ATGAGGTCGGTCTCACTACC-3‘ 57C 
IL-1b 5‘-CCTGTGTAATGAAAGACGGC-3‘ 5‘-GGTGCTGATGTACCAGTTGG-3‘ 58C 
β-actin 5‘-AATCGTGCGTGACATCAAAG-3‘ 5‘-ATGCCACAGGATTCCATACC-3‘. 59C 
Nfkbiz (L S) 5'-TCCAGAATGTCCCAGTCTCC-3' 5'-GAGTCTCAGTTTGGGGTGGA-3' 60C 
Nfkbiz (L D) 5'-CGACACCGGCTACCTGTC-3' 5'-CACCAAGGTTTACCAGATCTTG-3' 60C 
Nfkbiz (L ) 5'-CGCTCAACCTGGCTTACTTC-3' 5'-GGGCTCAACTTGAGGGCG-3' 60C 
IL-21 5'-
ATCCTGAACTTCTATCAGCTCCAC-3' 
5'-GCATTTAGCTATGTGCTTCTGTTTC-
3' 
58C 
Rorc s 5'-AGGGGATTCAACATCAGTGC-3' 5'-AGGGGATTCAACATCAGTGC-3' 59C 
IL-22 5'-TCATCGGGGAGAAACTGTTC-3' 5'-CATGTAGGGCTGGAACCTGT-3' 58C 
Runx 1 5'-TACCTGGGATCCATCACCTC-3' 5'-GACGGCAGAGTAGGGAACTG-3' 59C 
Ahr 5'-AGCAGCTGTGTAGATGGTG-3' 5'-CTGAGCAGTCCCCTGTAAGC-3' 60C 
Irf4 5'-GCAGCTCACTTTGGATGACA-3' 5'-CCAAACGTCACAGGACATTG-3' 58C 
Batf 5'-TGACGCTCAACGTGAGAAG-3' 5'-GAGCTGCGTTCTGTTTCTCC-3' 59C 
Socs3 5'-AGCTCCAAAAGCGAGTACCA-3' 5'-TGACGCTCAACGTGAAGAAG-3' 59C 
Ccr6 5'-TCCAGGCAACCAATCTTTC-3' 5'-GATGAACCACACTGCCACAC-3' 59C 
Ccl20 5'-CGACTGTTGCCTCTCTCGTACA-3' 5‘-CACCCAGTTCTGCTTTGGAT-3‘ 58C 
EGR-1 5'-AGGAGATGATGCTGAGC-3' 5'-GAGGATTGGTCATGCTCACGA-3' 58C 
EGR-3 5-TACCCCAATCGGCCTAGCAAGA-3‘ 5‘-CAGGGTCGCTCGGTGTTCGA-3‘ 58C 
IL-6 5‘-TGGTCTTCTGGAGTACCATAGC- 5‘-ACTCCTCTGTGACTCCAGC-3‘ 58C 
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3‘ 
IFNg 5‘-CCATCAGCAACAACATAAGC-3‘ 5‘-AGCTCATTGAATGCTTGGCG-3‘ 58C 
IL-4 5‘-CAAACGTCCTCACAGCAACG-3‘ 5‘ -CTTGGACTCATTCATGGTGC-3‘ 57C 
Gm-CSF 5'-TGGTCTACAGCCTCTCAGCA-3‘ 5'-CCGTAGACCCTGCTCGAATA-3‘ 57C 
E2f2 5'-TTGGATCCCAGTCAATCCCT-3‘ 5'-AAGTGATAGTCAAGGGCCTC-3‘ 58C 
IL-10 5'-GGTTGCCAAGCCTTATCGGA-3' 5'-ACCTGCTCCACTGCCTTGCT-3' 59C 
IL-15 5'-GATGAACATTTGGACAATGCG-3' 5'-AGAAACGTGCTCTACCTTGC-3' 60C 
RORGT 5'-GGAGCTCTGCCAGAATGACC-3‘ 5'-CAA GGC TCG AAA CAG CTC CAC-
3‘ 
58C 
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Table 2-4. Forward and Reverse human primers used for Real Time quantitative PCR 
 
2.8 Flow cytometry 
Flow cytometry is a powerful tool for the multi-parameter analysis of cells. This system senses 
cells as they pass through a liquid stream through a laser or light beam that emits coherent light 
at a specified wavelength. Scattered and emitted fluorescent light is collected by two lenses, one 
set in front of the light source (forward scatter) and one set at right angles (side scatter). Intensity 
of fluorescence is measured in specific bands. This technique shows the expression of cellular 
markers by a mixed population of cells. We used antibodies that have high affinity for the 
protein of interest and are usually conjugated to a fluorescent marker to enable detection. The 
computer then plots this data so that the expression of the markers by the cells can be quantified. 
Primer Sense Antisense Annealing Temperature 
IL-17 5'-ACCAATCCCAAAAGGTCCTC-3‘ 5'-CCCACGGACACCAGTATCTT-3‘ 58C 
EGR-3 5'-AGCAGCGACTCGGTAGTCC-3‘ 5'-TGATGTTGTCCTGGCACCAGT-3‘ 58C 
EGR-2 
5‘-CTTTGACCAGATGAACGGAG-
3‘ 
5‘-CCCATGTAAGTGAAGGTCTG -3‘ 58C 
EGR-1 5'-TGACCGCAGAGTCTTTTCCT-3‘ 5'-AGCGGCCAGTATAGGTGATG-3‘ 57C 
Beta-Actin 5'-AGAAAATCTGGCACCACACC-3‘ 5'-AGAGGCGTACAGGGATAGCA-3‘ 58C 
B2M 5' -AGGTATCCAGCGTACTCCA -3‘ 5'-TCAATGTCGGATGGATGAAA-3‘ 58C 
IL-2 
5'-
CACAAACAGTGCACCTACTTCA-
3‘ 
5'-TCCGGTGAGTTTGGGATTC-3‘ 57C 
IL-10 5'-TTTAGGGTTACCTGGGTTGC-3‘ 5'-CCTGATGTCTGGGTCTTGG-3‘ 59C 
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In addition the computer can be directed to show only those cells in a certain population; a 
process termed gating. In this study, we gated on CD4
+
 populations to investigate the expression 
of various markers. Single cell suspensions were analysed on a LSRII (BD Immunocytometry 
Systems) and the data were analysed using FlowJo (Tree Star). 
 
2.8.1 Surface and intracellular staining 
CD4
+ 
T cells, Splenocytes and CNS infiltrating mononuclear cells after day 4 of culture were 
stimulated with PMA 0.5ug/ml and 0.5ug/ml Ionomycin was added in the presence of Golgi stop 
(1:1000), an inhibitor of cytokine secretion, for four hours at 37ºC. Wells of cells were pooled 
together with the same conditioning treatment for each WT and EGR-2cKO cells respectively. 
Cells were then harvested and spun down. Using BD cytofix/cytoperm plus 
fixation/permeabilization kit, supernatant removed and 300 ul of fixation buffer added to fix the 
cells and keep in the dark for 20 minutes. Cells were then washed with BD Perm/Wash twice and 
specific fluorchromes (Fluorescein isothiocyanate (FITC)-conjugated antibodies IFN-g, and IL-
4. Phycoerythrin (PE)-conjugated antibodies to IL-17A, IL-17F, CD127, CD25, 
CD69allophycocyanin (APC)-conjugated antibody to CD4)  added to the cells. Total splenocytes 
incubated next with the specific fluorescently labelled antibodies for 30mins at 4̊C and then 
washed with Perm/Wash and the cells were then resuspended in PBS ready to be analysed by 
flow cytometry. 
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2.9 Microarray 
To study whole gene expression of EGR-2 we performed a microarray using RNA from isolated 
naive CD4
+ 
T cells (using MACS columns) of WT and EGR-2 cKO mice that were stimulated 
for six hours with plate bound anti-CD3 (5ug/ml) or left unstimulated. Total RNA was first 
isolated using the trizol reagent as described in section 0 and then further purified using the 
Qiagen RNAeasy kit RNA clean up protocol according to the manufacturer‘s instructions. The 
experiment was performed ten times and the trizol lysates for each condition were pooled.The 
quantity and quality of the RNA was assessed by nanodrop. Only RNA of acceptable quality that 
had A260/A280 ratio in the range of 1.7 to 2.1 was used.The integrity of RNA was checked 
using an Agilent 2100 Bioanalyser with a RNA LabChip Kit. RNA integrity was evaluated using 
the RNA Integrity Number (RIN) and Poly-A RNA control (See Fig 2.6). The total RNA was 
analysed using MouseRef-8 v2.0 BeadChip expression array (Illumina). These Bead chip arrays 
consist of 50-mer oligonucleotide probes directed against ~24,000 well annotatedRefSeq 
transcripts, allowing us to study a vast number of genes in one array. The content is derived from 
the National Center for Biotechnology Information Reference Sequence (NCBI RefSeq) database 
and supplemented with probes derived from the Mouse Exonic Evidence Based Oligonucliotide 
(MEEBO) set, as well as exemplar protein-coding sequences described in the RIKEN 
FANTOM2 database. The probe labeling, array hybridization and data processing were carried 
out at the Microarray facility, Barts and London School of Medicine and Dentistry according to 
the manufacturer‘s instructions. Briefly these arrays were manufactured by chemically 
synthesizing the oligonucleotide probes covalently attached to 3 micron beads which are then 
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fixed inplace on the array. Total RNA is converted to double-stranded cDNA, followed by an 
amplification step [in vitro transcription] to generate labelled cRNA. Upon introduction of 
labelled test RNA sequences, the labelled RNA will hybridize to complementary sequences 
present on the array (cRNA) and the unbound RNA is then washed away. The array is then 
scanned to detect the bound cRNA via the fluorescent label providing a genome-wide 
transcriptional profile for that sample (see Figure 2-6). The data was first normalized using the 
cubic spline method and then returned to us for further analysis.We focused on genes that 
showed a difference of at least three-fold between wild-type and Egr-2 deficient CD4
+ 
T cells 
and excluded genes that had a Detection P value greater than 0.01. The differentially expressed 
genes were first grouped based on self-organizing maps (SOMs) by a clustering algorithm 
method. The SOM clusters were further clustered by a hierarchical clustering program to confirm 
the different profile (ArrayExpress accession: E-MEXP-1698,www.ebi.ac.uk/arrayexpress). The 
heat maps where generated by Dr Alistair Symonds. Results were validated by Real Time RT-
PCR using the primers listed above (Table 2-3 ). 
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Figure 2-6.Overview of using MouseRef-8 v2.0 BeadChip expression array (Illumina) 
Adapted 
from:http://support.illumina.com/downloads/wggex_direct_hybridization_assay_guide_(11322355_a).ht
ml.  
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2.10 Experimental Autoimmune Encephalomyelitis 
To study the effect EGR-2 has on the breakdown in tolerance in mice and to study T-cell-
mediated autoimmune disease we induced Experimental Autoimmune Encephalomyelitis (EAE) 
in EGR-2 cKO mice and WT mice. EAE is an animal model of brain inflammation. It is widely 
studied as an animal model of the human CNS demyelinating diseases, including multiple 
sclerosis (Martin 1997; Steinman 1999). We carried out EAE induction using a myelin 
oligodendrocyte glyco-protein (MOG)35-55/ CFA (EK-0111) (Hooke) according to the 
manufacturer‘s instruction. This work has been carried out at Brunel University and performed 
by Emma Ghiffari. Briefly: five twelve-week-old female mice of both WT and EGR-2 cKO mice 
were immunized first with a pre-filled syringe of MOG35-55in CFA emulsion. The emulsion 
provides antigen needed to expand and differentiate MOG-specific autoimmune T cells. Tissue 
dendritic cells pick up the antigen and take it to the draining lymph nodes, where priming of T 
cells takes place. We performed subcutaneous injection technique where we injected mice 
subcutaneously on upper and lower back with 0.1 ml of emulsion. Within 2 hours of injection of 
the emulsion, we intraperitoneally injected the first dose of pertussis toxin at 0.1 ml per mouse. 
Pertussis toxin enhances EAE development by providing additional adjuvant. PTX injection 
affects cell trafficking, development of Th17 cells and integrity of the blood-brain barrier. Up to 
22-26 hours after injection of the emulsion, we intraperitoneally injected the second dose of 
pertussis toxin into the mice at 0.1 ml of pertussis toxin. The mice were checked for signs of 
EAE daily (see EAE scoring Figure 2-7), starting on day 7 after the immunization.  
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Figure 2-7.EAE clinical scoring guide for mice 
EFR-2 cKO and WT mice were immunized with MOG peptides, Five mice for each were 
immunized at 12 weeks, and after seven days the severity of EAE was scored according to 
standard protocols on a scale of 0 to 4,  0 being normal and 4 being paralysis. 
 
2.10.1 Haematoxylin and eosin staining 
30 days after EAE induction, using sacrificed mice, their CNS tissues were fixed with 10% 
formalin in PBS and embedded in paraffin. Sections are next stained with haematoxylin and 
eosin. Histological examination of tissue sections were done in a blind manner. In addition, CNS 
infiltrating mononuclear cells were isolated and analysed for IL-17 and IFNγ producing CD4+ T 
cells by intracellular cytokine staining.  
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2.11 Multiple Sclerosis patients 
Eleven relapsing and remitting Multiple Sclerosis (MS) patients in remission and five healthy 
donors were enrolled to this study. All MS patients were retrieved from the MS center Queen 
Mary University of London, Barts and the Royal London Hospital, London. The study has been 
approved by our ethics committee, trial number NCT01767701. All patients were diagnosed as 
having relapsing remitting multiple sclerosis according to the McDonald criteria (Polman, 
Reingold et al. 2005), were drug naive in relation to disease-modifying therapy and were in 
clinical remission. Blood was taken according to standard protocols, using heparinized tubes, 
after signed informed consent was obtained. Patient characteristics are presented below. 
Table 2-5  Patient Profile 
 
 
     SEX  AGE  Disease Course 
MS 1  male  29 RRMS 
MS 2 female  26 RRMS 
MS 3 female  56 RRMS 
MS 4 female  32 RRMS 
MS 5 male  37 RRMS 
MS 6 male  42 RRMS 
MS 7 male  38 RRMS 
MS 8 male  44 RRMS 
MS 9 female  33 RRMS 
MS 10 female  45 RRMS 
MS 11 female  39 RRMS 
 
RRMS = Relapsing Remitting               All patients untreated 
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Table 2-6 Healthy Controls Profile and Average age of Patient and Controls 
 
 
 
2.11.1 Peripheral blood mononuclear cells extraction from patient whole 
blood 
For in vitro isolation of patient whole human blood lymphocytes we used Ficoll-Paque
 TM
 PLUS 
(Amersham Biosciences). This is a density gradient medium that purifies high yields of 
lymphocytes using a rapid centrifugation procedure based on the method developed by Boyum 
(1976). Standard protocol was used. Briefly: for lymphocyte separation, defibrinated or 
anticoagulant-treated blood diluted with an equal amount of serum-free RPMI and layered 
carefully over Ficoll-Paque PLUS (without intermixing) in a centrifuge tube. After a short 
centrifugation at room temperature with break off as not to disturb the layers (2500rpmfor 30 
min), lymphocytes, together with monocytes and platelets, are harvested from the interface 
between the Ficoll-Paque PLUS and sample layers (see Figure 2-8). This material is centrifuged 
twice in PBS to wash the lymphocytes and to remove the platelets. 
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Adapted from Amersham website 
 
CD4
+
T cells were isolated from blood lymphocytes by positive selection using MACS systems 
(Miltenyi Biotec) and stimulated in vitro for 48 hours with anti-CD3 and anti-CD28 before 
restimulation for six hours with the same stimuli. Total RNA extracted from these cells, and 
unstimulated cells, was analysed for Batf, Egr-2 and IL-17A expression by real-time quantitative 
PCR (RT QPCR).  
Before centrifugation 
After centrifugation 
PBMC in Buffy layer 
Figure 2-8. Whole human blood lymphocytes we used Ficoll-Paque
 TM
 PLUS 
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2.12 Western Blot and Immunoprecipitation 
To analyse proteins we preformed Immunoprecipitation and Western Blot techniques. 
Immunoprecipitation allows for precipitation and isolation of a protein antigen out of solution 
using specifically binding antibodies to the protein of interest. Cells were first lysed with cold 
0.5ml Immunoprecipitation Buffer (150nM Nacl, 10mM Tris-HCL, 1mM EDTA, 1mM EGTA, 
0.2 mM sodium ortho-vanadate, 0.2mM PMSF, 1% triton x-100, 0.5% NP-40). Cells were 
agitated constantly for 30 minutes at 4°C and sonicated on ice for five seconds and repeated four 
times. They were then centrifuged five minutes at 4°C and assayed for total protein at 1mg/ml. 
To get rid of protein that binds non-specifically to the beads we used 25ul protein A/G magnetic 
beads (New England Biolabs) to 200ul of cell extract. This was vortexed and incubated for one 
hour. A magnetic field was applied for 30 seconds to pull beads to the side of the tube. 
Supernatant was then put in to another microcentrifuge tube and beads discarded. Anti c-jun or 
antiflag were added at 1:1000 and incubated at 4°C for one hour. Protein A/G magnetic beads 
were added at 25ul and incubated further one hour. Magnetic field was applied to pull beads to 
the side of the tube and supernatant was removed. Cells were washed with Immunoprecipitation 
buffer and magnetic field applied again and supernatant removed and discarded; this was 
repeated twice. 
Bead pellet was then resuspended in 30ul of 3x SDS sample loading buffer (187.5mM Tris-HCL, 
SDS, 30% glycerol, 150mM DTT, 0.03% bromophenol blue, 2% β-mercaptoethanol). Sample 
was then incubated at 70°C for five minutes. Magnetic field was then applied to the sample then 
supernatant was loaded on SDS-PAGE gel and electrophoresed.  
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Western Blot was performed using a 10% resolving gel; composed of 10% acrylamide: 0.26% 
bisacrylamide solution (ProtoGel), 0.1% SDS, 0.1% Ammonium Persulphate (APS), 0.04% 
N,N,N',N' - tetramethylethylenediamine (Temed) and 380mM Tris pH8.8; and a 5% stacking gel; 
composed of 5% acrylamide: 0.13% bisacrylamide solution (ProtoGel), 0.1% SDS, 0.1% APS, 
0.1% Temed and 187.5mM Tris pH6.8. The protein samples were mixed with loading buffer 
containing SDS and β-2-mercaptoethanol and then heated to 95°C for five minutes to denature 
and reduce the proteins. The protein samples, and 5μl of Rainbow molecular marker 
(Amersham), were loaded into the wells of the gel and a potential difference of 100V was 
applied for 1.5 hours. After separation by electrophoresis the proteins were transferred to a 
nitrocellulose membrane by a wet transfer protocol. The gel was placed on top of a nitrocellulose 
membrane (Amersham) and this was sandwiched between two pieces of filter paper. This was 
placed in a cassette in the wet transfer system and a current of 300mA applied for one hour. The 
negatively charged proteins move towards the anode but are unable to pass through the 
nitrocellulose membrane and hence are retained on this surface in the same orientation as in the 
gel. To prevent antibody binding non-specifically, the membrane was blocked in 5% milk in 
TBST (Tris Buffered Saline with 0.1% Tween [a detergent]) for one hour at room temperature. 
The membrane was then incubated overnight at 4°C with the relevant primary antibody against 
Myc, Bactin, phospho Stat 3, and phosphorylayted c-Fos (R and D systems) in 5% milk in TBST 
at a 1:1000 dilution. These antibodies were raised by immunizing a rabbit with a peptide derived 
from the protein of interest. Therefore the antibody will bind to any protein containing this 
sequence present on the membrane. The following day any unbound primary antibody was 
removed by washing the membrane three times in TBST. The membrane was then incubated 
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with a polyclonal goat anti-rabbit IgG HRP (horseradish peroxidase) secondary antibody 
(Biorad) in 5% milk in TBST, at a 1:2000 dilution, for one hour at 4°C with rotation. This 
secondary antibody, raised in goat against rabbit antibody, is conjugated to the reporter enzyme 
HRP to enable detection. The membrane was then washed three times in TBST and once in TBS 
to remove any unbound secondary antibody and then transferred onto cling film. The immune 
complexes were detected by chemiluminescence using the ECL Plus kit (GE Healthcare) 
according to the manufacturer‘s instructions. This reagent contains a substrate that is oxidised, 
catalysed by HRP, producing a luminescent signal. Following exposure to ECL Plus for five 
minutes, the luminescence was detected by exposing photographic film to the membrane and 
then developing the film. 
2.13 EMSA 
Probes corresponding to a Batf binding site in the IL-17 promoter; 
TGGTTCTGTGCTGACCTCATTTGAGGATG (nucleotides -155 to -187) (10) were labelled 
with [-32P] dCTP using Ready-to-Go DNA labeling beads (Amersham Biosciences UK Ltd., 
Pollards Wood, Bucks) and used in binding reactions with nuclear extracts. Nuclear extracts 
were obtained as described in our previous report (26). For supershift reactions anti-Batf were 
added after 10 minutes of incubation. The samples were electrophoresed on 5% polyacrylamide 
gels in 0.5 x TBE. 
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2.14 Reporter gene assay 
Mouse Batf, Egr-1, Egr-2, and Egr-3 cDNAs were introduced into pcDNA expression vectors by 
PCR-cloning approaches. The reporter plasmid IL17-Luc and the indicated expression plasmids 
were transfected into a specific cell line, HEK293 (Human Embryonic Kidney  293 cells) T cells 
using FuGENE 6 (Roche). After 36 hours a dual luciferase assay (Promega) was performed 
according to the manufacturer‘s protocol. This work was performed by Dr Tizong Miao. 
2.15 Lentiviral transduction 
The lentiviral constructs used were described previously (Miao, Wu et al. 2006). Egr-2 was 
introduced into these constructs by a PCR cloning approach. In addition to Egr-2, the construct 
carries an IRES driven GFP which allows us to isolate transduced cells by fluorescence activated 
cell sorting. Naive CD4
+
 cells from EGR-2cKO mice were seeded at 1 x 10
6 
per well in a 24-well 
plate coated with anti-CD3 and anti-CD28. This was  supplemented with 2ng/ml TGFβ, 20ng/ml 
IL-6, 10ug/ml anti-IFN and 20ug/ml anti-IL-4 and infected with concentrated lentivirus at a 
multiplicity of infection (MOI) of 50–100 (~105–106 transducing units/ng) as previously 
described (Miao, Wu et al. 2006). Two days after infection, fresh medium, supplemented with 
2ng/ml TGFβ, 20ng/ml IL-6, 10ug/ml anti-IFN and 20ug/ml anti-IL-4, was added. The cells 
were harvested after five days and the GFP positive cells were isolated by cell sorting. The 
isolated cells were used for RT-PCR analysis and analysis of IL-17 producing cells. This work 
was preformed under the supervision of Dr Tizong Miao. 
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2.16 RNA silencing 
A specific short interfering oligonucleotide (siRNA) targeting the mRNA sequence of Egr-2, 
siEgr-2-1, GCUGCUAUCCAGAAGGUAU was developed and used. Irrelevant scrambled 
siRNA obtained from QIAGEN, CAT:1027281, was used as a negative control. Primary naive 
CD4
+
 T cells isolated from 6 to 8 week old mice were transfected with 1 μM siRNA using an 
Amaxa Nucleofector according to the manufacturer‘s instructions. Cells were stimulated with 
anti-CD3 and anti-CD28; supplemented with 2ng/ml TGFβ, 20ng/ml IL-6, 10ug/ml anti-IFN 
and 20ug/ml anti-IL-4; for three days before analysis of Egr-2 and IL-17 expression. This work 
was preformed with Dr Tizong Miao. 
2.17 Statistics 
Student‘s unpaired t-test was used to analyse the statistical significance of differences between 
the groups. Differences with a p-value < 0.05 considered significant. 
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CHAPTER 3 
RESULTS 
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3 RESULTS 
3.0 Egr-2 is selectively deleted in CD4+ T cells from EGR-2 cKO mice 
To confirm the absence of Egr-2 in CD4
+
 T cells from genotyped Egr2-cKO mice and the 
presence of Egr-2 in WT mice, splenic CD4
+
 T cells were isolated respectively and stimulated 
with or without anti-CD3(5ug/ml) and anti-CD28 (3ug/ml). Both at the mRNA level and at the 
protein level Egr-2 was successfully deleted out in CD4
+
 T cell of Egr-2 cKO mice in both 
unstimulated and stimulated conditions (Figure 3-1 A and B). CD4
+
 T cells from WT mice 
expressed Egr-2 and were highly expressed upon activation. 
 
 
Figure 3-1. Egr-2 is successfully knocked out of CD4
+
 T cells from EGR-2 cKO mice 
(A) , RNA was extracted from CD4
+
T cells from WT and cKO mice, in either unstimulated or 
stimulated with anti CD3 and anti CD28. Real time QPCR was preformed to measure EGR-2 
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expression. (B), To confirm results we also checked the protein level by Western blot for WT and 
cKO CD4
+ 
T cells  with and without anti CD3 and anti CD28.   
 
 
3.1 No change in CD4+ T cell proliferation without Egr-2 but change 
in phenotype. 
The T cell proliferation in Egr-2 cKO mice was compatible to that in wild-type mice (Figure 3-2 
A-C), which is consistent with our previous report (Wang, Zhu et al. 2008). However, Egr-2 
cKO mice developed autoimmune syndromes at late age (Zhu, Symonds et al. 2008) indicating a 
dysregulatory homeostasis (Wang, Zhu et al. 2008). The phenotype of the CD4
+
 T cells from 
mice age at two months showed that there were increased populations of CD25
+
CD4
+
 and 
CD44
high
CD4 cells detected from Egr-2 cKO mice (Figure 3-3), which is consistent with our 
previous report (Wang, Zhu et al. 2008). The increased effector phenotype of Egr-2 cKO T cells, 
suggest that T cells are less tolerant under homeostatic conditions.  
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Figure 3-2.No change in T cell proliferation in EGR-2cKO and WT mice 
BrdU assay showing cell division over four days of CD4
+
 T cells from Egr-2KO and WT mice. 
Cells were treated with 10µM BrdU and incubated for 30 mins. Using a goat anti mouse 
secondary antibody S phase cells were detected by FACS. Cells were also stained for 7AAD to 
exclude non-viable cells [(A) and (B)]. Isolated CD4
+
 T cells from Egr-2cKO and WT mice were 
stimulated with anti CD3 at the indicated concentrations for 72 hours, 1μCi of [3H]TdR was 
added to each well for the last eight hours of culture. Tritium incorporation was measured by 54 
scintillation counting (C). 
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Cell surface staining, anti CD4, anti CD44 and anti CD25, on CD4
+ 
T cells from WT and Egr-2 
cKO mice. Egr-2 cKO mice had higher number of CD4
+
CD44
+
CD25
+ 
thymic effector phenotype 
cells compared to WT mice.  
 
WT                        Egr-2 cKO 
Figure 3-3. Increased percentage of thymic effector phenotype cells in Egr-2 cKO mice 
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3.2 Egr-2 controls expression of Th17, but not Th1 or Th2, 
cytokines in effector CD4 T cells 
 
Th differentiation is driven by the cytokine environment induced by specific antigens or with 
polarization protocols in vitro (Stockinger, Veldhoen et al. 2007). In the absence of polarization 
conditions, naive CD4
+
 T cells are activated and entered into cell cycles under low 
differentiation state in vitro. To assess the impact of Egr-2 on cytokine production by activated 
naive CD4
+
 T cells, naïve CD62L
+
CD44
low
CD4
+
 T cells were isolated by cell sorter and 
activated in vitro by anti-CD3 and anti-CD28 stimulation. As expected, a high level of IL-2 was 
detected in WT naïve CD4 T cells following anti-CD3 and anti-CD28 stimulation in vitro for 16 
hours (Figure 3-4). 
120 
 
 
 
Figure 3-4. IL-2 expression is activated in naive CD4
+
 T cells upon stimulation 
Expression of IL-2 cytokine from naive CD4
+
 T cells from Wild-type (WT) mice in unstimulated 
conditions or stimulated with anti-CD3 (5ug/ml) and anti- CD28 (3ug/ml) for 16 hours in vitro. 
Expression of IL-2 was measured by Real Time qPCR and normalized to house keeping gene β-
actin. Data is representative of three independent experiments. 
 
The Th cytokines such as Th1 cytokines IFNγ, Th2 cytokine IL-4 and Th17 cytokine IL-17, were 
barely detected in the absence of unstimulated polarization conditions (Figure 3-5A and B). In 
contrast to the wild-type CD4 T cells, a broad spectrum of inflammatory cytokines were detected 
following anti-CD3 and anti-CD28 stimulation, but in the absence of polarization conditions in 
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vitro (Figure 3-5A) suggesting that Egr-2 represses inflammatory responses following T cell 
receptor stimulation (TCR) when there is no cytokine environments. Previously, we found that, 
in association with the development of lupus-like disease, Egr-2 deficiency induced high 
expression of IL-17 and IFN-γ in effector T cells isolated from aged mice (Zhu, Symonds et al. 
2008).  
To look at global expression of EGR-2 we preformed Bead Chip microarray, which showed  
following TCR stimulation, Egr-2 deficient naive CD4
+
 T cells produced similar expression 
levels of IL-2 and IFN-γ in comparison to wild-type counter-parts, however, the Th17 associated 
cytokines such as IL-1, IL-17 and IL-21 were highly expressed in Egr-2-deficient naive CD4
+ 
T 
cells on stimulation in comparing to the minimum production of Th17 cytokines in wild-type 
CD4
+
 T cells (Figure 3-6 ). The scatterplot shows the closeness of EGR-2 to the other 
inflammatory cytokines on stimulation (Figure 3-7). From the results IL2, and IFN-γ remain 
unchanged from unstimulated to stimulated setting , while IL17A and Il17F is highly expressed 
in cKO upon stimulation and has moved closer to the X axis (Figure 3-7).   
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Figure 3-5. Expression of Th cytokines in stimulated and unstimulated conditions in the absence of 
polarized conditions 
CD4
+ 
 T cells from WT mice and cKO mice in unstimulated or stimulated conditions with anti-
CD3 (5ug/ml) and anti- CD28 (3ug/ml) for 16 hours in vitro. Relative expression of Th cytokines 
was measured by Real Time qPCR (A) and Surface cell expression of Th cytokines by FACS (B). 
Data is representative of three independent experiments. 
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Figure 3-6. Egr-2 deficiency leads to enhanced expression of Th17 cytokines in naive CD4
+
 T cells in 
response to TCR stimulation as seen from Beadchip expression microarray. 
(A) Naive CD4+ T cells were stimulated with or without anti-CD3 for six hours. Extracted RNA was 
analysed by genome-wide transcriptional profiles using MouseRef-8 v2.0 BeadChip expression array 
(Illumina). (A) Altered expression of cytokine and cytokine receptor genes in Egr-2–deficient CD4+T cells 
as assessed by genome-wide transcriptional analysis. The SOM cluster of cytokines was further clustered 
by a hierarchical clustering program to show the genes with differential expression profiles. Genes were 
grouped to into specific cellular pathways with green showing very low intensity expression and red high 
intensity expression. Genes highlighted in red where genes of interest. We focused on genes that had at 
least three-fold difference between WT and Egr-2 cKO mice. (B and C) Heat maps showing the Z score, 
which measures how many deviations away from the mean. Blue indicates negative deivations below the 
mean and red indicates positive deviations above the mean. 
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Figure 3-7. Upon stimulation Egr-2 is closely associated to inflammatory cytokines.  
Scatter plots (D and E) , to visualize key cytokines and  show the spread of genes in unstimulated 
conditions (D) or stimulated conditions (E) against WT and cKO samples. Each point represents 
an expression value. The purple dotted diagonal line represents equal expression, The further 
the gene is to X axis the higher the expression is to cKO, the closer to the Y axis the higher the 
expression is to WT.  
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The globe analysis of transcripts can give false results. It is therefore required validation of 
individual genes by real-time PCR with house keeping gene (β-actin) as a control. We analysed 
the Th17 cytokines detected by microarray by RT-PCR with primers specific for the regions 
including last two exons of the cytokine genes. Indeed, relative expression of those Th17 
cytokines in Egr-2-deficient CD4
+
 T cells was significantly increased in comparing to the wild-
type CD4
+
 T cells following TCR stimulation (Figure 3-8). 
Therefore, the overall increased transcription of Th17 cytokines in Egr-2-deficient CD4
+ 
T cells 
was confirmed. Although the transciption of Th17 cytokine genes indicate the Th17 effect, it is 
important to measure the cytokine proteins in CD4
+
 T cells to determine weather the cytokine are 
produced and also the levels of cytokine producing cells. Thus, intracellular cytokines were 
measured by intracellular staining with specific antibodies. To investigate the IL17-producing 
CD4
+
 T cells following TCR stimulation, the stimulated cells were stained intracellularly with 
anti-IL17A. Again, IL17 positive CD4
+
 T cells were barely detected in wild-type CD4
+
 T cells, 
while the percentage of Egr-2-deficient CD4
+
 cells that produced IL-17 was also increased 
(Figure 3-9). 
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Figure 3-8. Enhanced expression of Th17 cytokines in naive CD4 T cells in response to TCR 
stimulation 
Egr-2 deficient (Egr-2 cKO) and Wild-type (WT)naive CD4+ T cells were stimulated for 16 
hours with anti CD3 5ug/ml and anti CD28 3ug/ml. Cytokine expression was measured by RT-
qPCR and normalized to housekeeping gene β-actin and represents three independent 
experiments. P value < 0.05 
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Figure 3-9. IL17-A producing CD4+T cells 
 
Intracellular cytokine staining of CD4+ T cells isolated from WT (Wild type) and EGR-2 cKO 
mice splenocytes for three hours with 100ng/ml PMA/ionomycin in vitro. This is representative 
of one of three independent experiments. 
 
We have now discovered a novel function of Egr-2 in the control of Th17 cytokine production 
during TCR stimulation in CD4
+
 T cells. Therefore, Egr-2 may be involved in the control of 
Th17 cytokine expression in effector T cells.  
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3.3 Egr-2 is induced in naive CD4+ T cells by TGFβ and IL-6 
Th differentiation is induced by polarized cytokine environment (Harrington, Mangan et al. 
2006). Most of the cytokines responsible for differentiating Th subsets are produced by T cells 
(Powrie and Coffman 1993). It has been well defined that TGFβ and IL-6 can differentiate 
activated CD4
+
 T cells to Th17 cells and these cytokines can be produced by activated T cells 
(Mangan, Harrington et al. 2006; Veldhoen, Hocking et al. 2006). If Egr-2 is antagonist for Th17 
differentiation, it may be present under TGFβ and IL-6 conditions. Egr-2 is however not 
expressed in naive T cells (Anderson, Manzo et al. 2006). Egr-2 can be induced by antigen in 
vitro and in vivo in naive T cells (Harris, Bishop et al. 2004; Safford, Collins et al. 2005; 
Anderson, Manzo et al. 2006; Zhu, Symonds et al. 2008). These inductions are triggered by the 
activation of NFAT pathway (Decker, Nehmann et al. 2003). Although an overproduction of 
inflammatory cytokines has been discovered in Egr-2-deficient T cells (Zhu, Symonds et al. 
2008), it is not known if it can be induced by any cytokine in CD4
+
 T cells. The excessive 
production of IL-17 suggests that Egr-2 may be expressed under Th17 conditions and negatively 
regulate Th17 differentiation. Previously, we found that Egr-2 is effectively induced in naive T 
cells by antigen stimulation in vivo (Anderson, Manzo et al. 2006). The selective induction of 
Th17 cytokines in Egr-2-deficient CD4
+ 
T cells by TCR stimulation indicates that Egr-2 controls 
the expression of Th17 cytokines in T cells in response to mitogenic antigen stimulation. TGF 
and IL-6 are effective inducers for Th17 differentiation and they signal through Smad and 
STAT3 pathways, respectively (Zhou, Chong et al. 2009). These pathways are not activated 
through TCR signaling  (Hirahara, Ghoreschi et al. 2010). However, TCR stimulation can induce 
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both expressions in naive CD4
+ 
T cells (Hirota, Martin et al. 2010). Whether TGFβ and IL6 can 
induce Egr-2 expression is unknown. We therefore examined the expression of Egr-2 in naive T 
cells following stimulation with different cytokines in the absence of TCR stimulation in vitro. 
The results showed that Egr-2 is rapidly induced in naive T cells following TGF and IL-6 
stimulation (Figure 3-10 A). In contrast, IFN, IL-12 and IL-4; cytokines that can induce Th1 
and Th2 differentiation, respectively; had little effects on Egr-2 expression in naive CD4
+
 T cells 
(Figure 3-10 A). 
The transcriptional activation of Egr-2 gene is induced in T cells by anti-CD3 stimulation 
(Anderson, Manzo et al. 2006). It has been found that this induction is mediated by NFAT and 
can be inhibited by cyclosporin A (CsA) (Harris, Bishop et al. 2004). It is therefore a mechanism 
involving in the induction of anergy (Safford, Collins et al. 2005; Zhu, Symonds et al. 2008). 
Consistent with this, we found that Egr-2 was strongly induced by anti-CD3 in naive CD4
+
 T 
cells and the expression of Egr-2 was suppressed by CsA (Figure 3-10 B). As TGFβ and IL-6 
signal through Smad and STAT3 pathways, respectively (Zhou, Chong et al. 2009). It is not 
known if TGFβ and IL-6 induce activation of the NFAT pathway for Egr-2 expression in T cells. 
To test this, the naive CD4
+ 
T cells from wild-type mice were stimulated with TGFβ and IL-6 in 
the presence or absence of CsA inhibitor for NFAT signaling. The induction of Egr-2 by TGFβ 
and IL-6 was not suppressed by CsA (Figure 3-10 B). This result indicates that the induction of 
Egr-2 in CD4
+
 T cells by TGFβ and IL-6 is not mediated by NFAT which differs from the 
induction of Egr-2 in CD4
+ 
T cells by T cell receptor stimulation. It therefore suggests that Egr-2 
is induced by different signaling pathways: by TCR stimulation and TGFβ and IL-6. Egr-2 is one 
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of the Egr family members (Egr-1, -2, -3 and -4:(Swirnoff and Milbrandt 1995). Egr-1, -2 and -3 
share structure similarities and have overlapped function within T cell development (Shao, Kono 
et al. 1997; Carter, Lefebvre et al. 2007). All three are also induced by TCR stimulation through 
activation of NFAT pathway (Aifantis, Gounari et al. 2001; Lazarevic, Zullo et al. 2009). 
However, Egr-1 and -3 knockout mice did not display autoimmune syndromes. To investigate 
whether these two Egr molecules play similar role in Th17 induction, we analysed expression of 
Egr-1, -2 and -3 in CD4
+
 T cells under the same conditions of TGFβ and IL-6 stimulation. 
Although Egr-1 and Egr-3 share similar functions with Egr-2 in the regulation of thymocyte 
development (Kaye 2000), TGF and IL-6 did not induce expression of either of these 
transcription factors (Figure 3-10 C). These results further suggest that Egr-2 is selectively 
involved in the regulation of Th17 cytokines in effector CD4
+
 T cells and Th17 differentiation. 
The induction of Egr-2 by TGFβ and IL-6 in naive CD4+ T cells during antigen stimulation may 
provide a feedback mechanism to prevent immune pathology induced by Th17 responses during 
adaptive immune responses.  
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Figure 3-10. Th17 differentiation cytokines increase the expression of Egr-2 specifically compared 
to the other Egr- subtypes and these cytokines are not inhibited by CSA 
(A and B) Expression of Egr-2 in naive CD4 T cells from wild-type mice following stimulation 
with the indicated cytokines (A) or with 5 mg/ml anti-CD3 and 2 mg/ml anti-CD28 or TGF-b/IL-
6 in the absence or presence of 250 ng/ml CsA (B) for 6 h. (C) Expression of Egr-1, Egr-2, and 
Egr-3 in naive CD4 T cells from wild-type mice following stimulation with TGF-b, IL-6, or both. 
mRNA expression was measured by RT-qPCR and data represents three independent 
experiments (A, B and C). 
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3.4 Egr-2 regulates Th17 differentiation 
Differentiation of Th subsets is regulated by the function of distinct transcription factors 
(Hirahara, Ghoreschi et al. 2010). These include master regulators, RORγt and STAT3 which 
drive Th17 differentiation (Ivanov 2006; Harris, Grosso et al. 2007). However, recently a 
number of transcription factors have important roles in Th17 differentiation and plasticity 
(Brustle, Heink et al. 2007; Schraml, Hildner et al. 2009; Okamoto, Iwai et al. 2010). Egr-2 is 
induced in T cells in response to TCR stimulation (Anderson, Manzo et al. 2006). Therefore, it is 
expressed in all types of the Th cells. We have now found that TGFβ and IL-6, but not by the 
other the cytokines known for Th1 and Th2 differentiation can induce EGR-2, indicating that 
Egr-2 may selectively control  Th17 differentiation. However, although Egr-2 is not induced by 
Th1 and Th2 cytokines, it does not automatically exclude the function in the control of Th1 and 
Th2 differentiations. To investigate whether Egr-2 regulates the differentiation of CD4
+
 T cells, 
naive CD4
+
 T cells were isolated from wild-type and Egr-2-deficient mice and were stimulated 
with anti-CD3 and anti-CD28 under different Th polarization conditions (Stockinger, Veldhoen 
et al. 2007). In the absence of Egr-2, naive CD4
+
 T cells did not alter Th1 and Th2 differentiation 
(Figure 3-11 A). The percentage of Th1 cytokine producing and Th2 cytokine producing cells 
were compatible to wild-type counter-parts (Figure 3-11 A). Similar to the cytokine producing 
cells, the levels of cytokine expression in positive Th1 or Th2 cells were also at normal 
expression (Figure 3-11 A). However, an Egr-2 defect rendered CD4
+
 T cells more susceptible to 
differentiation into Th17 cells than naive CD4
+ 
T cells from wild-type mice (Figure 3-13 A). 
Following Th17 differentiation in vitro, the expression of several Th17 cytokines, including IL-
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17 and IL-21, was increased in CD4
+ 
cells differentiated from Egr-2 deficient naive CD4
+ 
T cells 
(Figure 3-11 B). 
Although Egr-2, but not Egr-1 and -3, was induced by TGFβ and IL-6, all three Egr molecules 
were induced in Th1, Th2 and Th17 cells in response to anti-CD3 stimulation (Figure 3-11C). 
However, in the absence of TCR stimulation, the Th1 and Th2 cytokines did not induce Egr-2 
expression, while Th17 cytokines did (Figure 3-11C). In contrast, Egr-2 expression persisted in 
Th17 cells in the absence of anti-CD3 stimulation (Figure 3-11C), further supporting the notion 
that Egr-2 is induced by both the Th17 environment and antigen receptor stimulation. Although 
in the absence of Egr-2, naive CD4
+
 T cells are susceptible for Th17 differentiation, it may result 
from altered cytokine production during the differentiation rather than impact of Egr-2 directly. 
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Figure 3-11. Egr-2 controls Th17 differentiation 
(A) Naive CD4
+
 T cells were differentiated into Th subsets Th1, Th2, and Th17 as described in 
materials and methods. Expression of cytokines was measured by intracellular staining of 
antibodies to IL17A and IFNγ and IL-4 for confirmation of differentiation to Th17 Th1 and Th2 
respectively. (B) Relative mRNA expression of IL-17A, IL-17F and IL-21 from TH17 
differentiated cells of naive CD4 T cells WT and EGR-2 cKO mice. (C) Expression of Egr-1, 
Egr-2, Egr-3, and Batf in Th1, Th2, and Th17 polarized cells from WT mice, stimulated for 6 
hours with or without 5 µg/ml anti-CD3 and 2 µg/ml anti-CD28. Data (D) represents 5 
experiments (B and C) represent 3 independent experiments. 
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To further define the role of Egr-2 in the control of IL-17 expression, we applied the lentiviral 
system to re-introduce Egr-2 expression in Egr-2-deficient CD4
+
 T cells. The open-reading 
frame of Egr-2 was cloned by PCR from mRNA of mouse CD4
+
 T cells following TCR 
stimulation into a Lentiviral construct in which GFP gene is operated by IRSE (Figure 3-12D). 
Which allows us to isolate transduced cells by fluorescence –activated cell sorting .The Egr-2 
gene was orientated from 5‘ to 3‘ under CMV promoter (Figure 3-12E). 
 
 
Figure 3-12. Cloned open reading frame of Egr-2 in Lentiviral construct 
(D) Egr-2 was introduced into lentiviral construct by PCR cloning approach. In addition to Egr-
2, the construct carries an IRES-driven GFP. A Map of vector sites from a plasmid containing 
the cloned open-reading frame of Egr-2   (E) The Egr-2 gene was orientated from 5’ to 3’ under 
CMV promoter Maps were created by Vector NTI by Invitrogen. 
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The positive clones were sequenced to confirm the integrity of Egr-2 gene. Lentivirus was 
replicated in packaging cells (Miao, Wu et al. 2006). A stock of 10
12
/ml was harvested and 
stored in liquid nitrogen. To increase the transduction efficiency, the Egr-2-lentivirus was 
incubated with naive CD4
+
 T cells throughout the in vitro culture. The Egr2 positive cells were 
identified and isolated based on GFP signal. Lentivirus without insert was served as control. 
Thus, we reconstituted Egr-2 expression in CD4
+ 
T cells from Egr-2 cKO mice before Th17 
differentiation (Figure 3-13 A). The restoration of Egr-2 expression in naive CD4
+ 
T cells from 
Egr-2-deficient mice reduced the percentage of IL-17 producing CD4
+ 
T cells after Th17 
differentiation in comparison to the naive CD4
+
 T cells transduced with control lentivirus (Figure 
3-13 B and C). 
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Figure 3-13. Regulating Egr-2 expression alters Th17 expression 
(A) CD4 T cells from Egr-2 cKO mice were transduced with Egr-2-lentivirus-IRES–GFP (Egr-2) 
or lentivirus-IRES–GFP (control) and the GFP+ cells were analysed for the relative expression 
of Egr-2 by Real Time QPCR. (B)These transduced cells were then differentiated in to Th17 
cells. The GFP
+ 
cells were analysed for mRNA relative expression of IL-17A by Real Time qPCR 
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or (C) for cytokine producing cells of IL17A and IFNγ as measured by FACS. Data (A and B) 
represents three independent experiments; (C) represents two independent experiments. 
 
To further confirm the function of Egr-2 in the control of Th17 differentiation, the normal 
expression of Egr-2 in naive CD4
+ 
T cells was knocked down by Egr-2 specific siRNA (Figure 
3-14 A). The Egr-2-specific siRNAs selectively reduced Egr-2 expression in wild-type CD4
+
 T 
cells following stimulation while control siRNA did not (Figure 3-14 A). Consistently, 
knockdown of Egr-2 expression by siRNA, in wild-type CD4
+
 T cells resembled the altered 
Th17 differentiation of Egr-2-deficient CD4
+
T cells. With enhanced fraction of IL-17 producing 
CD4
+
 T cells following Th17 differentiation (Figure 3-14 A, B and C). Thus, Egr-2 selectively 
controls Th17 differentiation and expression of Th17 cytokines, which is consistent with the 
selectively altered expression of Th17 cytokines in naive CD4
+ 
T cells from Egr-2 cKO mice in 
response to TCR stimulation (Figure 3-5A). 
Considering the overlapped function between Egr-2 and Egr-3, we also examined Th17 
differentiation in Egr-3-deficient CD4
+
 T cells in vitro. This dysregulation of Th17 
differentiation was not observed in Egr-3 deficient naive CD4
+
 T cells (data not shown). 
Although the normal phenotype of Th17 differentiation from Egr-3-deficient CD4
+
 T cells may 
result from the function of wild-type Egr-2, our results at least demonstrate that among the Egr 
molecules, Egr-2 predominantly control the Th17 differentiation. Thus, Egr-2 plays an important 
role in the control of Th17 differentiation. 
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Figure 3-14. Knocking out Egr-2 alters TH17 expression 
(A) CD4
+ 
cells from wild-type mice were differentiated into Th17 cells after transfection with 
siRNAs against Egr-2 or control siRNA. The transfected cells were cultured under Th17 
conditions for 3 days (see Materials and Methods) before analysis of Egr-2 expression or (B) IL-
17A expression or (C) for cytokine producing cells of IL17A and IFN-γ as measured by FACS 
Data (A and B) represents three independent experiments; (C) represents two independent 
experiments. 
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3.5 Egr-2 interacts with Batf and blocks its binding to the IL-17 
promoter 
Th17 differentiation is regulated by a number of master regulatory molecules. However, the 
repressors for Th17 differentiation and plasticity are largely unknown. In order to investigate the 
mechanisms by which Egr-2 controls Th17 differentiation, we analysed the major regulatory 
pathways involved in the differentiation of Th17 cells. Despite the increased Th17 
differentiation, we did not find differences in the expression levels of the well-defined regulators 
such as RORγt/RORc, IRF4, aryl hydrocarbon receptor (Ahr), Iκbδ, or Batf by RT-PCR (Figure 
3-15) indicating that Egr-2 is not involved in the control of transcriptional activation of these 
genes. Altered cytokine expression in effector phenotype CD4
+
 T cells has been found in aged 
Egr-2 deficient mice (Zhu, Symonds et al. 2008). A few of the inflammatory cytokines sign 
through STAT3 pathways which are also involved in IL-6 signaling pathway during Th17 
differentiation (Harris, Grosso et al. 2007). However, we could not detect altered activation of 
STAT3 in Egr-2-deficient Th17 cells (data not shown). 
When we examined transcriptional activity, we discovered that the binding of Batf to DNA 
binding sites from the IL-17 promoters in Th17 cells was significantly increased in the absence 
of Egr-2 (Figure 3-16A), suggesting that Egr-2 may control Batf function in the regulation of IL-
17 expression. Batf is required for Th17 differentiation and expression of IL-17 (Schraml, 
Hildner et al. 2009). The function of Batf is independent to  the other Th17 regulators (Schraml, 
Hildner et al. 2009). Similar to Egr-2, Batf was induced in Th1, Th2, and Th17 cells in response 
to anti-CD3 stimulation (Figure 3-16 C), suggesting that the antagonistic function of Egr-2 and 
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Batf  in Th17 differentiation is conditional.  Despite the increase in binding to Batf sites in the 
IL-17 promoter, we did not find increased expression of Batf in naive CD4
+
 T cells or Th17 cells 
derived from Egr-2 cKO mice (Figure 3-16 B), suggesting that Egr-2 does not transcriptionally 
regulate Batf. Thus, Egr-2 either directly inhibits Batf function or regulates Batf‘s repressors in 
Th17 cells. To investigate whether Egr-2 antagonizes Batf function directly, we analysed Batf 
immunoprecipitates from wild-type CD4
+
 T cells after TCR stimulation. The immunoprecipitates 
of anti-Batf antibody were analysed by immunoblotting with anti-Batf and anti-Egr-2 antibodies, 
respectively. Both Egr-2 and Batf were discovered in the Batf precipitates (Figure 3-16 C). 
 
Figure 3-15. No difference in expression levels between WT and Egr-2 cKO mice in well defined 
transcription factors related to Th17 
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WT and Egr-2 cKO CD4
+
T cells were differentiated to Th17 cells and mRNA expression levels 
were measured by Real Time qPCR for transcription factors, Batf, Ahr, Runx 1, IRF4, Rorc and 
Nfkbiz (L D) (a gene that encodes IκBδ ). Data is representative of three individual experiments. 
 
 
Figure 3-16.Interaction of Batf with EGR-2 blocks IL17 promoter 
(A) Interaction of Batf from Th17 cells with a DNA sequence derived from the IL-17 promoter. 
The differentiated Th17 cells were restimulated with or without anti-CD3 and anti-CD28 for 6 h 
before nuclear proteins were extracted and analysed by EMSA. (B) Expression of Batf in Th17 
cells from wild-type and Egr-2 cKO mice. The differentiated Th17 cells were restimulated with 
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or without anti-CD3 and anti-CD28 for 6 h. The expression of Batf was analysed by RT-qPCR. 
(C) Naive CD4
+ 
T cells from WT or Egr-2 cKO mice were stimulated with or without anti-CD3 
and anti-CD28 for 36 hrs and then restimulated with the same stimuli for 6 h. The nuclear 
proteins were extracted and used for immunoprecipitation with anti-Batf. The precipitates were 
blotted with anti–Egr-2. The data represents two experiments (A and C) and three experiments 
(B). 
To confirm whether other Egr molecules are also involved in the Batf complex, Batf precipitates 
were blotted by anti-Egr-1 and -3 antibodies, respectively. Neither Egr1 nor Egr3 were found in 
Batf precipitates (Figure 3-17A).Thus, Egr-2 and Batf directly interact in CD4
+
 T cells raising 
the possibility that Egr-2 may regulate Batf  by directly blocking its binding to promoters of 
Th17 cytokines. To further analyse the antagonistic function of Egr-2 in the regulation of Batf 
mediated IL-17 expression, we took advantage of an available IL17-reporter construct 
(Okamoto, Iwai et al. 2010). This reporter consists of 25kb region up stream of reading frame of 
IL17A gene (Okamoto, Iwai et al. 2010). Thus, we were able to  measure the activity of an IL-
17-promoter reporter gene (Okamoto, Iwai et al. 2010) in the presence of Batf alone or together 
with Egr-1, Egr-2 or Egr-3. In the presence of Batf, the trans-activation of the reporter gene was 
detected in comparing to the control reporter (data not shown). 
So, Egr-2 directly suppresses Batf function in the induction of IL-17 expression. Batf is also 
involved in activation of other Th17 cytokine expression such as IL-21 (Schraml, Hildner et al. 
2009). Although we did not have a reporter construct for the IL-21 gene, the altered expression 
of IL-21 in Egr-2-deficientCD4
+
 T cells following Th17 differentiation indicates that Egr-2 is 
involved in the control of Th17 cytokine expression resulting in the suppression of Th17 
differentiation.  
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The trans-action of  the reporter induced by Batf was suppressed by co-transfection of Egr-2, but 
not Egr-1 or -3. Egr-2 effectively suppressed Batf mediated trans-activation (Figure 3-17 B). 
 
Figure 3-17 . Only Egr-2 not Egr-1or Egr-3 interacts with Batf 
(A) Naive CD4 T cells from wild-type or Egr-2 cKO mice were stimulated with or without anti-
CD3 and anti-CD28 for 36 h and then restimulated with the same stimuli for 6 h. The nuclear 
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proteins were extracted and used for immunoprecipitation with anti-Batf. The precipitates were 
blotted with anti-Egr-1 and anti-Egr-3. (B) IL-17 promoter reporter gene assay. The IL-17 
promoter-reporter gene was co-transfected with the indicated genes into HEK293T cells. Cells 
were stimulated with PMA and ionomycin for 30 min before reporter gene activity was 
measured. The data presented is a  fold increase above the background signal from reporter 
gene transfected cells. 
 
3.6 Egr-2 cKO mice are susceptible to the induction of Experimental 
Autoimmune Encephalomyelitis (EAE) 
Th17 cells are the major pathological T cells in the development of EAE. Experimental 
autoimmune encephalomyelitis (EAE) is the most commonly used experimental model for the 
human inflammatory demyelinating disease, multiple sclerosis (MS). EAE is a complex 
condition in which the interaction between a variety of immune pathological and 
neuropathological mechanisms leads to an approximation of the key pathological features of MS: 
inflammation, demyelination, axonal loss and gliosis. The counter-regulatory mechanisms of 
resolution of inflammation and remyelination also occur in EAE, which, therefore can also serve 
as a model for these processes. Moreover, EAE is often used as a model of cell-mediated organ-
specific autoimmune conditions in general (Constantinescu, Farooqi et al. 2011). It has been 
reported that Batf deficiency results in resistance to EAE induction owning to the reduction of 
Th17 cells in disease animals (Schraml, Hildner et al. 2009). To examine whether the control of 
Th17 differentiation by Egr-2 can affect immune pathology in autoimmunity, we examined 
disease progression in mice after immunization with the myelin protein in the presence of 
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complete adjuvants as described. (Schraml, Hildner et al. 2009). The disease progression is 
monitored according to the clinical score systems (Bettelli, Carrier et al. 2006). Since Egr-2 cKO 
mice develop spontaneous autoimmunity in later life, naive mice aged 10-12 weeks, well before 
the onset of autoimmunity, were used for the induction of EAE. We discovered that the onset of 
the diseases was similar in wild-type and Egr-2 cKO mice (Fig3.12A) suggesting that Egr-2 
deficiency in T cells did not affect the autoimmune responses against self-antigens. However, the 
disease was more severe in Egr-2 cKO mice compared to wild-type mice as demonstrated by 
higher clinical scores (Figure 3-18 A). 
To confirm the cellular mediated autoimmunity, infiltration of mononuclear cells into 
inflammatory lesions in spinal cords was examined when mice were scored 3 or above (Figure 
3-18 B and C). 
The infiltration of mononuclear cells were detected in spinal cords of both wild-type and Egr-2 
cKO mice (Figure 3-18 B). However, the levels of infiltration in Egr-2 cKO mice were much 
severer than wild-type mice (Figure 3-18 B). The levels of IL-17 expressing CD4
+ 
T cells were 
also analysed in mononuclear cells from spinal cords of diseased mice. The percentage of CD4
+
 
T cells in infiltrated mononuclear cells in inflamed spinal cords of Egr2 cKO mice was higher 
than that of wild-type mice (Figure 3-18B). Importantly, the infiltrated CD4
+
 T cells expressing 
IL-17A were more in Egr-2 cKO mice than in wild-type mice (Figure 3-18 C). 
Although we cannot rule out the effect of other inflammatory factors, these results suggest that 
Egr-2 is important for the control of Th17 cell driven pathology and for the control of the 
development and severity of autoimmune disease. Thus, consistent with the development of 
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lupus like autoimmune disease in aged Egr-2 cKO mice, these results demonstrate that the 
regulatory function of Egr-2 in the control of Th17 differentiation and cytokine expression is 
important for the control of autoimmunity.  
 
Figure 3-18. EGR-2 cKO mice are more susceptible to EAE induction 
(A) Timeline showing the clinical scores of five 12-week-old WT or Egr-2 cKO mice immunized 
with MOG peptides. The clinical symptoms were scored according to standardprotocols (see 
Materials and Methods).(B) H&E staining of CNS tissues from two (I and II) diseased mice 30 
days after immunization of MOG EAE peptide. Original magnification x10. (C) Mononuclear 
cells pooled from CNS tissues from five diseased mice in each group were stained with anti 
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human CD4, anti human IFN-γ, and anti human IL-17A. The data shown are after gating on 
CD4
+
 cells. The data are representative of three experiments with five mice for each group.  
3.7 Altered expression of Egr-2 and IL-17 in T cells from Multiple 
Sclerosis patients 
The severe EAE observed in Egr-2 cKO mice suggests that Egr-2 maybe involved in the control 
of multiple sclerosis development. It has been found that IL-17 is highly expressed in central 
nervous system-infiltrating T cells and glial cells and is associated with active disease in multiple 
sclerosis (MS) (Tzartos, Friese et al. 2008). Based on the increased production of IL-17 in Egr-2 
deficient CD4
+
 T cells and the high susceptibility of Egr-2 cKO mice to EAE induction, it 
suggests that Egr-2 may be important for the control of MS development. Egr-2 is expressed at a 
basal level in naive T cells and is rapidly induced by TCR stimulation. To investigate the 
possible role of Egr-2 in the control of MS development, we analysed the expression of Egr-2, 
Batf and IL-17 in T cells from MS patients. Our hypothesis is that the high level of IL-17 
positive T cells in MS patients may associate with defective Egr-2 function. To investigate this, 
we isolated CD4
+ 
T cells from peripheral blood lymphocytes of treatment-naive MS patients. 
The CD4
+ 
T cells were stimulated with anti-CD3 and anti-CD28 in vitro for 48 hours or left 
unstimulated, and then the expression of Egr-2, Batf and IL-17 was analysed by RT-PCR. 
Consistent with the expression patterns in murine naive T cells, the expression of Egr-2 and Batf 
in T cells from healthy donors was highly induced in response to TCR stimulation (Figure 3-19 
A and C), while IL-17 was barely detected (Figure 3-19 B).  
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However, in CD4
+
 T cells from MS patients, although the levels of Batf induced in response to 
TCR stimulation were similar to that seen in healthy donors, the levels of Egr-2 expression were 
significantly lower among the patients tested (Figure 3-19 A and C). In contrast to the reduced 
expression of Egr-2, the mean expression of IL-17 in patient group was increased in T cells from 
MS patients compared with healthy controls (Figure 3-19B). Due to limited availability of 
patient CD4
+ 
T cells, we were not be able to manipulate CD4
+ 
T cells from patients for 
transduction of Egr-2 or knockdown of Batf. Therefore, we do not know whether the 
downregulation of Egr-2 and increased expression of IL-17 is associated with uncontrolled Batf 
activity in T cells from MS patients. Nevertheless, our results provide direct evidence that Egr-2 
expression in effector T cells may be important for the control of Th17-mediated inflammation 
which is believed to be part of the mechanism underlying MS development. 
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Figure 3-19. Altered expression of Egr-2 and IL17A in CD4 T cells but not Batf in patients with MS 
CD4 T cells were isolated from blood lymphocytes of 11 treatment-naive MS patients and five 
healthy donors and stimulated withanti-CD3 and anti-CD28 for 48 h. The cells were then 
restimulated for 6 hand the expression of Egr-2 (A), IL-17A (B), and Batf (C) was analysed by 
RT-qPCR. The data are represented relative to the expression of mRNA of β-actin and from two 
experiments. **p, 0.01. 
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4 DISCUSSION 
4.0 Discussion 
Regulation of Th differentiation and plasticity is the centre part of adaptive immunity. Although 
most of the master regulators such as T-bet for Th1, Gata3 for Th2 and RORγt for Th17 have 
been well defined for their requirement for differentiation, the regulatory mechanisms for these 
master transcription factors and the molecules control the plasticity of differentiated Th cells are 
still largely unknown. Th17 is closely associated with autoimmune pathology and found to be 
present in many autoimmune diseases such as MS, lupus and IBD (Jadidi-Niaragh and 
Mirshafiey 2011; Henriques, Ines et al. 2012; Hundorfean, Neurath et al. 2012). Despite the 
requirements of RORgt and STAT3 in the differentiation of Th17, recently, it has been found 
that IRF4, aryl hydrocarbon receptor (Ahr), Iκbδ, and Batf are also required for Th17 
differentiation (Brustle, Heink et al. 2007; Veldhoen, Hirota et al. 2008; Schraml, Hildner et al. 
2009; Okamoto, Iwai et al. 2010; Mudter, Yu et al. 2011). However, among them, Batf functions 
independent on RORγt and STAT3 (Schraml, Hildner et al. 2009). Batf is a transcription factor 
that directly binds to cis-regulatory regions of multiple Th17 cytokines such as IL-17 and IL-21 
during Th17 differentiation (Betz, Jordan-Williams et al. 2010). Egr-2 has been discovered to be 
involved in T cell tolerance (Harris, Bishop et al. 2004; Safford, Collins et al. 2005; Anderson, 
Manzo et al. 2006). Its function in T cells is largely unknown (Li, Symonds et al. 2011). 
Previously, we found that Egr-2 is induced in both tolerant and naive T cells following antigen 
stimulation in vivo and deficiency of Egr-2 in T cells results in the development of lupus-like 
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disease in later life with accumulation of activated T cells (Zhu, Symonds et al. 2008). However, 
although Egr-2 is highly induced in naive T cells following antigen stimulation (Anderson, 
Manzo et al. 2006), a defect in Egr-2 does not increase T cell activation in response to TCR 
stimulation, suggesting a role in T cell differentiation (Zhu, Symonds et al. 2008). We have now 
demonstrated that Egr-2 deficiency results in uncontrolled production of Th17 cytokines in naive 
CD4
+
 T cells in response to TCR stimulation and renders CD4
+
 T cells prone to Th17 
differentiation, which contributes to increased susceptibility to EAE induction. The importance 
of Egr-2 in the control of Th17 driven pathology is further supported by the defective induction 
of Egr-2 and increased expression of IL-17 in T cells from treatment-naive MS patients. 
Th17 cells, one of the major Th subsets, can be generated by differentiation of naive CD4
+ 
T 
cells in response to antigen and Th17 mediators such as IL-6 and TGF(Hirota, Martin et al. 
2010; Ghoreschi, Laurence et al. 2011). However, in contrast to Th1 and Th2 cytokines, such as 
IFN- and IL-4, which are highly induced in naive T cells in response to T cell receptor ligation, 
the induction of Th17 cytokines, such as IL-17 and IL-21, was barely detected in activated naive 
T cells from wild-type mice in the absence of Th17 mediators. This suggest that the expression 
of Th17 cytokines in effector T cells is tightly regulated. A number of regulatory factors have 
been discovered for inhibiting expression of Th17 cytokines and regulating Th17 differentiation 
(Ivanov 2006; Brustle, Heink et al. 2007; Harris, Grosso et al. 2007; Veldhoen, Hirota et al. 
2008; Schraml, Hildner et al. 2009; Hirahara, Ghoreschi et al. 2010; Hirota, Martin et al. 2010; 
Okamoto, Iwai et al. 2010; Ghoreschi, Laurence et al. 2011). Most of them act by inhibiting the 
expression, or antagonizing the function, of RORt, such as Runx1, T-bet and by inhibiting 
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STAT3 activation, such as SOCS3, or by promoting Foxp3 expression, a counter-activator 
essential for Treg development (Hirahara, Ghoreschi et al. 2010). The RORγt was unchanged in 
Egr-2-deficient CD4 T cells under Th17 differentiation conditions. Batf is one of the newly 
discovered transcription factors that have regulatory function in Th17 differentiation (Schraml, 
Hildner et al. 2009). In contrast to many other regulatory factors, Batf acts directly to Th17 
cytokines such as IL17 and IL21 for their transactivation (Betz, Jordan-Williams et al. 2010). It 
does not however affect the Th1 and Th2 differentiations (Schraml, Hildner et al. 2009), 
suggesting that its function for Th17 cytokine expression is antagonized in Th1 and Th2 cells. 
We have now found that Egr-2 interacts with Batf to suppress Th17 cytokine expression. Despite 
the structure similarity and overlapping function in T cell development (Decker, Nehmann et al. 
2003), we could not detect Egr-1 and -3 in anti-Batf precipitates (data not shown) suggesting a 
selective interaction between Egr-2 and Batf. In contrast to the suppression of RORt expression 
in Th1 and Th2 cells, Batf is induced in all types of effector CD4 T cells in response to TCR 
ligation (Schraml, Hildner et al. 2009), suggesting that its Th17-promoting function is 
suppressed in effector T cells to avoid unwanted Th17 differentiation. TCR stimulation induces 
expression of both Egr-2 and Batf in all types of effector Th cells. The induction of Th17 
cytokines, such as IL-17 and IL-21, in Egr-2-deficient T cells following TCR stimulation 
suggests that Egr-2 plays an important role in the control of Th17 cytokine expression in CD4 T 
cells in response to mitogenic antigen stimulation. The antagonistic function of Egr-2 on Batf in 
the regulation of Th17 cytokines in effector T cells may be essential for the control of Th17-
mediated immunopathology during an adaptive immune response. Although Egr-2 and Batf are 
induced by TCR stimulation in all types of Th cells, we found that Egr-2 is selectively induced 
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by TGF and IL-6, but not IL-4, IL-12, or IFN, indicating a feedback mechanism involving 
Egr-2 that serves to control Th17 differentiation. TGFβ and IL-6 signal through STAT3 and 
Smad pathways, respectively (Harris, Grosso et al. 2007; Yang, Panopoulos et al. 2007; 
Martinez, Zhang et al. 2009), which are distinct from TCR signaling pathways. Induction of Egr-
2 by both TCR and TGFβ suggests that Egr-2 induction can be regulated by multiple stimuli with 
distinct signaling pathways, which may be coordinated in T cells during adaptive immune 
responses. Although the mechanisms for the induction of Egr-2 expression by TGFβ and IL-6 are 
unknown, the increased expression of Egr-2 in Th17 cells indicates that the induction of Egr-2 
expression and Th17 differentiation by TGFβ and IL-6 are likely to occur via similar 
mechanisms, which have yet to be fully investigated.  
The importance of Egr-2 in the control of immune pathology in autoimmune diseases is 
highlighted by the susceptibility of Egr-2 cKO mice to the induction of EAE. The increased 
severity of disease and enhanced infiltration of inflammatory cells in Egr-2 cKO mice is 
associated with high levels of IL-17 producing CD4 T cells. The high susceptibility of Egr-2 
cKO mice to EAE induction is stark contrast to the reduced EAE induction in Batf deficient mice 
(Schraml, Hildner et al. 2009) indicating that the repression of Batf function by Egr-2 contributes 
to the development of EAE. EAE is cellular mediated autoimmune diseases with complex 
pathological changes (Constantinescu, Farooqi et al. 2011). The resistance of RORγt and/or 
STAT3 knockout models to EAE induction indicates complex regulatory mechanisms for Th17 
pathology in EAE (Ivanov 2006; Yang, Panopoulos et al. 2007). It is therefore unlikely that Batf 
is the most important factor in EAE development. Nevertheless, the resistance for EAE induction 
157 
 
demonstrates the importance of Batf in the development of Th17-mediated autoimmune diseases 
(Schraml, Hildner et al. 2009). Thus, the susceptible EAE development in Egr2 cKO mice 
highlights the function of Egr-2 in the control of autoimmune diseases with likelihood 
mechanisms for inhibiting Batf function.  
The defective expression of Egr-2 and its association with increased production of IL-17 in CD4
+
 
T cells from treatment-naive MS patients is consistent with previous reports (Tzartos, Friese et 
al. 2008) and further indicates that impaired expression of Egr-2 in activated T cells may 
contribute to MS development. Egr-2 expression was found to be important for T cell tolerance 
and its expression in anergic T cells is regulated by NFAT (Harris, Bishop et al. 2004; Lazarevic, 
Zullo et al. 2009). The dysregulated expression of Egr-2 and IL-17, but normal induction of Batf, 
in CD4
+
 T cells from MS patients resemble the expression profile of these molecules in CD4
+ 
T 
cells from Egr-2 cKO mice, suggesting that uncontrolled Batf activity may contribute to the 
increased IL-17 production and immunopathology in MS.  
Taken together, this study has demonstrated a previously unknown function of Egr-2 in the 
control of Th17 cytokine expression and Th17 differentiation by inhibition of Batf function. The 
susceptibility of Egr-2 cKO mice to EAE induction and the reduced induction of Egr-2 in T cells 
from MS patients after TCR stimulation further indicate the importance of Egr-2 in the control of 
autoimmunity and Th17-mediated inflammation. 
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Future Work  
If I had more time, I would have liked to have developed the MS pilot study, to increase the 
number of patients and healthy controls, to also look at the protein level for these samples and 
other possible biomarkers.  I would also like to have performed ELISA‘s to verify cytokine 
production from the polarized Th conditioned CD4
+ 
 T cells , and CHIP analysis to look at more 
detail at binding sites.  
 
Publications from my work    
Early growth response gene-2 controls IL-17 expression and Th17 differentiation by 
negatively regulating Batf.  (Joint first author paper). 
Miao, T., M. Raymond, et al. (2013). J Immunol 190(1): 58-65. 
The transcription factors Egr2 and Egr3 are essential for the control of inflammation and 
antigen-induced proliferation of B and T cells. 
Li S
1
, Miao T, Sebastian M,  et al (2012)  
Early Growth Response Gene-2 (Egr-2) Regulates the Development of B and T Cells.  
Li S, Symonds ALJ, Zhu B, Liu M, Raymond MV, et al. (2011). PLOS ONE 6(4):  
168 
 
Early Growth Response Gene-2 (EGR-2) Regulates Inflammatory Plasticity of Effector T 
Cells. 
Raymond MV, Maio T, Symonds ALJ, Li S and Wang P.  (2011)  J.Immunol. 186:167.1 (Abstr) 
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